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Chapter 1

Introduction

1

Musculoskeletal impairments associated with diabetes mellitus (DM) have been
disproportionately understudied though they often lead to reported functional limitations and
disability. Furthermore, individuals with diabetes mellitus and peripheral neuropathy (DMPN)
have nearly three times the rate of functional mobility deficits associated with lower extremity
impairment than their non-diabetic counterparts1,2. The focus of this research is on DM and its
related complications, specifically the examination of the contribution of a specific gait
impairment, an excessive external foot progression angle (FPA), on the lower extremity
impairment cascade of medial neuropathic plantar ulcer (NPU) development and subsequent
non-traumatic lower extremity amputation in individuals with DMPN (Figure 1).

1.1.

Diabetes mellitus: Healthcare burden and clinical relevance

1.1.a. Prevalence.
Diabetes mellitus (DM) is a chronic and progressive metabolic disease characterized by
elevated blood glucose secondary to insufficient insulin output and insulin resistance, leading to
impaired glucose uptake and suboptimal neuromuscular function3,4. Medical management of
DM represents a major national and international healthcare burden, with total estimated costs
of treatment and management of $174 billion in the United States5. The World Health
Organization (WHO) estimates a worldwide prevalence of DM of 347 million people4, while the
Centers for Disease Control and Prevention estimate a prevalence of approximately 25.8 million
Americans (8.3% of the population)5. In the United States, 90-95% of those with DM have type
2 diabetes (T2DM), of which Black/African American (13.1 per 1000), Hispanic/Latino (12.3 per
1000), and American Indian/Alaska Native (11.8 per 1000) race groups have a
disproportionately higher prevalence compared with White Americans (8.7/1000)5.
1.1.b. Complications of diabetes mellitus.
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1.1.b.1. Peripheral neuropathy. An observed long-term complication of DM is peripheral
neuropathy, defined as a clinical diagnosis of peripheral nerve impairment resulting in
dysfunction affecting the sensory, motor, and autonomic nervous systems6,7. The proposed
pathogenesis for the onset and progression of peripheral neuropathy features a complex
interaction of vascular and metabolic factors that result in ischemic nerve injury8,9. Peripheral
neuropathy follows a heterogeneous clinical course with an equally varied manifestation of
progressive clinical symptoms, and is estimated to affect up to 60-70% of individuals with
chronic DM in the United States 6, 7,10-12. The most prevalent form of peripheral neuropathy is
the distal symmetric polyneuropathy classification in which sensory and motor changes occur
symmetrically in the lower and upper extremity 10, 13. This is also referred to as the “stocking
and glove distribution” of peripheral nerve symptoms13. Clinical symptoms are insidious and
progressive in nature, characterized by a transition from acute sensory changes such as varying
degrees of hyperalgesia (an exaggerated response to a noxious stimulus) and allodynia (a pain
response to a non-noxious stimulus) to paresthesia (numbness, tingling), abnormal reflexes,
and muscle performance deficits6. Diagnostic screening for the presence of diabetic peripheral
neuropathy includes tests of protective sensation, lower extremity perfusion, and selfassessments of function6. The chronicity of peripheral neuropathy is purported to contribute to
the development of diabetic foot disease, a cluster of lower extremity pathologies that often lead
to pain, morbidity, loss of function and disability6,14.

1.1.b.2. Diabetic foot disease. Diabetic foot disease carries a substantial economic
healthcare burden. Treatment and management of diabetic foot disease in the United States
costs approximately $4.6-13.7 billion annually, and often culminates in non-traumatic lower
extremity amputation 6,15. The hallmarks of diabetic foot disease are demineralization and
structural malalignment of the pedal bones, excessive regional peak plantar pressure,
3

neuropathic plantar ulceration, and acute or chronic foot infection in individuals with DM14.
There are more than 65,000 non-traumatic lower extremity amputations in adults with DMPN
annually in the United States, 84% of which are preceded by neuropathic plantar ulcers
(NPUs)5,16. Sinacore et al (1987) showed that 64-81% of NPUs are located on the medial side of
the foot compared to the lateral side of the foot17.

1.1.b.3. Neuropathic plantar ulceration. The development and recurrence of neuropathic
plantar ulcers (NPUs) are a significant health and economic burden worldwide. In the United
States, an estimated 12 to 25% of adults will develop an NPU18,19. Furthermore, those with a
history of NPU have the highest relative risk for re-ulceration or new ulcer development
(RR=2.46; 95% CI: 1.84-3.29)20. Peak plantar pressure (PPP) is often used as an index of risk
for skin injury in individuals with DMPN21,22. People with DMPN with history of NPU have
greater PPP in regions of the foot vulnerable to ulceration compared to those with no history of
NPU23,24. The combined effects of elevated PPP, limited joint mobility of the foot and ankle, lack
of somatic sensation in the foot, and impairments in autonomic nerve function that lead to dry
skin and callus formation contribute to the relative risk of NPU development25. The
development and recurrence of NPUs in individuals with DMPN are related to gait adaptations
that compensate for limited joint mobility and impaired muscle performance of the foot and ankle
joint complex 26-28.

1.1.b.4. Gait dysfunction. Individuals with DMPN often exhibit the following gait abnormalities:
1) decreased gait speed, 2) excessive external FPA or ‘toe-out angle’, and 3) prolonged stance
time 26,28,29-32. These gait adaptations have been linked to the protracted timing and magnitude
of regional plantar stresses in areas of the foot at risk for skin injury in individuals with DMPN
27,32

. Foot progression angle, or “toe-out angle,” is a spatial gait characteristic defined by the

orientation of the longitudinal axis of the foot in the transverse plane with respect to the direction
4

of progression during gait33,34. Previous reports have established normative values for FPA
magnitude as ranging from 5-9⁰ in older and younger healthy adults with an accompanying
degree of asymmetry (inter-limb differences) of at least 2⁰32, 35. Therefore, a reasonable
criterion for classification of excessive FPA is a measured FPA of greater than 10±5⁰.
Lower extremity joint mobility and gait speed. Reported lower extremity joint mobility
limitations related to slower gait speed include less 1st metatarsophalangeal joint (1st MTPJ)
extension motion, less ankle dorsiflexion motion, less ankle plantar flexor muscle power and
peak torque, and decreased hip rotation during walking compared with healthy, age and weightmatched control subjects27-29,36-39. In addition, Giacomozzi et al (2008) and Allet et al (2009)
suggest that decreased gait speed and the associated joint mobility impairments may precede
the onset or clinical detection of peripheral neuropathy in persons with diabetes mellitus31,38.
Lower extremity joint mobility and FPA. Studies from independent groups suggest a
direct relationship between external FPA and timing and magnitude of medial and lateral PPP in
adults with DMPN21,32. However, there is a dearth of evidence identifying specific joint mobility
limitations associated with excessive external FPA in individuals with DMPN. Similarly, it is not
known if changes in FPA characteristics (magnitude and inter-limb asymmetry) progress in
parallel with the severity of lower extremity impairments associated with DMPN, or if the
changes in FPA magnitude are modifiable. Studies from the pediatric orthopedic literature
provide some evidence for lower extremity joint limitations related to FPA magnitude. Ho et al
(2000) and Chang et al (2004) suggest greater ankle dorsiflexion and hip external (lateral)
rotation are related to increased FPA magnitude in children with and without neuromuscular
disease40,41 though these impairments have not been identified as contributors to excessive
FPA in adults with DMPN.
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1.2. Current neuropathic plantar ulcer (NPU) treatment options.

1.2.a. Bracing and custom footwear.
Many treatment options exist for offloading plantar sites to promote wound healing or to
prevent re-ulceration. Commonly used pressure offloading strategies include use of custommade insoles42, removable cast walking boots, total contact casting, and non-weight bearing
strategies such as wheelchair usage43. Though these interventions have been shown to
successfully reduce forefoot and mid foot PPP in individuals with DMPN and a history of
NPU43,44, often there are barriers related to cost, patient compliance, and reimbursement43,45.
Moreover, non-weight bearing offloading techniques potentially contribute to the development
and progression of mobility limitations reported by individuals with diabetes5. Though offloading
strategies may provide the proper healing environment for NPUs, excessive offloading may
make the tissues vulnerable to re-injury as evidenced by the high rates of re-ulceration (~2070%) after successful healing with offloading46,47.

1.2.b. Gait pattern modification.
Some research groups have investigated the effects of modified gait patterns on plantar
pressure distribution in healthy young adults and in adults with DMPN45,48,49. These modified
gait patterns were proposed as preventative or healing strategies for people with DMPN at risk
for first-time or recurrent NPU. Strategies for those with DMPN include walking slower, reducing
push off in late stance phase of walking by exaggerating hip flexion48, or walking with a “step-to”
gait pattern49. Though these strategies reduce PPP in the forefoot region, reported changes in
other regions of the plantar surface of the foot are variable. However, there have been no
documented results as to whether an excessive external FPA is modifiable in a DM population
with or without peripheral neuropathy, or the effects of such a modification.

6

1.3. Scope of dissertation
1.3 a. Unexplored areas of research
Despite the strong relationship between external FPA and the increased timing and
magnitude of medial plantar pressure21,32, there are no studies that have investigated the unique
features of FPA in individuals with DMPN. Also, to our knowledge, there are no studies that
have examined the specific joint mobility limitations associated with excessive external FPA in
individuals with DMPN. Furthermore, there have been no studies probing whether excessive
external FPA can be modified in adults with DMPN, thereby potentially creating a strategy for
early rehabilitative intervention in the lower extremity impairment cascade which often
culminates in amputation (Figure 1). Our research seeks to improve our understanding of the
lower extremity alignment factors that contribute to an excessive external FPA in adults with DM
with and without peripheral neuropathy, and if those factors are amenable to early intervention
using modification of walking patterns.
1.3.b. Expected outcomes
Based on previous published studies, we hypothesized that limitations in foot, ankle, and
hip range of motion contribute substantially to excessive external FPA in adults with DMPN2729,36-39

. We also hypothesized that after visual and verbal cueing and practice, adults with

DMPN would be able to intentionally reduce their external FPA, resulting in concomitant
decreases in PPP particularly in the medial side of the foot. Figure 1 illustrates the proposed
relationship between excessive external FPA and the lower extremity impairment cascade of
excessive medial PPP, medial neuropathic plantar ulceration, and non-traumatic foot
amputation. The primary objective of this research was to explore how specific characteristics
(magnitude and inter-limb asymmetry) of FPA change with disease progression (Aim 1), to
determine static and dynamic predictors of FPA magnitude (Aim 2), and to examine the effect of
7

a modification of external FPA magnitude on the regional plantar pressure distribution (Aim 3).
A portion of this project was to investigate the impact of limited hip joint rotation on external FPA
magnitude in individuals with DMPN (Aim 2). A particularly novel aspect of the project
represents a considerable expansion of previous literature on hip joint mobility in persons with
DM, which has only explored hip joint mobility limitations in the sagittal plane with respect to a
decreased gait speed39. Given that treatment for joint limitations are within the scope of
physical therapist practice, intervention(s) targeting lower extremity joint limitations could
potentially serve as treatment sites to minimize risk for NPU development in DMPN.
1.4. Specific Aims and Hypotheses

Specific Aim 1. Determine the characteristics of foot progression angle in groups of
participants without diabetes mellitus (CON), with diabetes mellitus without peripheral
neuropathy (DM only), with diabetes mellitus and peripheral neuropathy WITHOUT a
history of neuropathic plantar ulcers (DMPN-NPU) with diabetes mellitus and peripheral
neuropathy WITH a history of neuropathic plantar ulcers (DMPN+ NPU).
Hypothesis 1. The primary external FPA characteristic of interest is magnitude, but a
secondary characteristic of interest is inter-limb asymmetry (i.e., right side versus left side). We
hypothesize that individuals with DMPN+NPU will demonstrate an increased external FPA
magnitude compared with other groups.
Hypothesis 2. We hypothesize there will be a progressive decrease in inter-limb asymmetry of
FPA across participant groups with and without DMPN and a prior history of ulceration.

Specific Aim 2. Determine ability of select lower extremity joint variables to predict FPA
magnitude.
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Hypothesis 3. There will be an inverse relationship between FPA and peak ankle plantar
flexor power, as well as peak range of motion values for 1st MTPJ extension and ankle joint
dorsiflexion. There will be a direct relationship between FPA and hip external rotation range of
motion.
Hypothesis 4. Peak hip external rotation range of motion and ankle joint dorsiflexion range of
motion will account for at least 50% of the variance in external FPA magnitude during the stance
phase of gait.

Specific Aim 3. Determine the effect of reducing external FPA on medial peak plantar
pressure in individuals with DMPN with excessive external FPA. The primary objective is
to determine if reducing FPA using instruction, visual and verbal cues and practice trials results
in concomitant reductions in medial peak plantar pressure in adults with DMPN.
Hypothesis 5. Adults with DMPN who reduce their FPA magnitude to 10⁰ or less will
demonstrate decreased medial peak plantar pressure compared with pre-intervention values.

9
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Chapter 2

Characteristics of foot progression angle in individuals with diabetes mellitus and
peripheral neuropathy
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2.1

Abstract
In the United States, an estimated 15% of patients with diabetes mellitus and peripheral

neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development, which
often precedes non-traumatic lower extremity amputation. Despite evidence of the relationship
between excessive external foot progression angle (FPA or “toe-out angle”) and plantar
ulceration risk in individuals with DMPN, specific characteristics of FPA, e.g. magnitude and
inter-limb asymmetry have not been examined. The primary purposes of this study were to
describe the magnitude and inter-limb asymmetry (the difference in FPA between sides). Fortyfive participants with and without diabetes participated, and were classified into one of four
groups: 1) non-diabetic control (CON), 2) diabetes mellitus without peripheral neuropathy
(DM), 3) diabetes mellitus and peripheral neuropathy without a prior history of a neuropathic
plantar ulcer (DMPN-NPU), and 4) diabetes mellitus and peripheral neuropathy with a prior
history of a neuropathic plantar ulcer (DMPN+NPU). The foot with the higher external FPA
value was designated the High FPA foot for all groups, while the foot with the lower FPA value
was designated as the Low FPA foot. The DMPN+NPU group had a greater FPA on the High
FPA foot than the other groups (DMPN+NPU=-21±5⁰; DMPN-NPU=-13±7⁰; DM=-14±5⁰; CON=15±6⁰, p=.03), with no group difference in FPA on the Low FPA foot (DMPN+NPU=-15±9⁰;
DMPN-NPU=-9±5⁰; DM=-10±5⁰; CON=-8.7±4.8⁰, p=.07). There was no group difference in
degree of inter-limb asymmetry (FPA Diff). These results indicate that it may be useful to
include measurement of FPA magnitude as part of a clinical gait assessment for individuals
with DMPN with a prior history of ulceration.
2.2

Introduction
In the United States, an estimated 15% of patients with diabetes mellitus and peripheral

neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development1.
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Recent data show more than 65,000 non-traumatic lower extremity amputations in adults with
DMPN occur annually in the United States, with 84% preceded by the development of a NPU2,3.
The development and recurrence of NPUs in individuals with DMPN have been linked to the
protracted duration and magnitude of regional peak plantar pressure (PPP) in areas of the foot
at risk for skin injury secondary to altered gait characteristics4,5. Foot progression angle (FPA),
or “toe-out angle,” is a spatial gait variable defined by the orientation of the longitudinal axis of
the foot in the transverse plane with respect to the direction of progression during gait6,7.
Previously established normative values for FPA magnitude range from 5-9⁰ in older and
younger healthy adults5,8. Therefore, an accepted criterion for classification of excessive
external FPA (‘toe-out angle’) is a measured FPA of greater than 10±5⁰. Chang et al reported a
direct relationship between an excessive external FPA and the increased duration and
magnitude of medial PPP in children with neurological pathology9. Other investigators have
established FPA as a predictor of elevated medial PPP, a proxy measure of dermal injury risk in
adults with DMPN with a history of plantar ulceration5,10. However, findings from this previous
work have been conducted primarily on the affected limb. Despite evidence of the direct
relationship between increased external FPA and PPP in individuals with DMPN, it is unknown if
FPA magnitude during the stance phase of walking changes in parallel with the severity of lower
extremity impairments associated with DMPN.
Inter-limb symmetry of gait patterns is becoming more widely accepted as a measure of
functional lower extremity motor control and coordination11-13. Though there is evidence to
support asymmetry in spatiotemporal gait parameters, muscle performance measures, and joint
mobility as indicators of gait pathology, there is equally compelling evidence to support
asymmetry of these variables as a normal feature of gait14. In a review by Sadeghi et al (2000),
several investigators have reported asymmetries in step and stride lengths, external FPA, and
joint kinematics and kinetics in healthy people without lower extremity pathologies14.
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Researchers have often attributed the presence of any minor inter-limb asymmetry in gait
variables to “limb dominance” and to the differential functions of braking and propulsion, or the
deceleration and acceleration of the body during gait14. Researchers have reported values of
inter-limb asymmetry in FPA ranging from 2-4⁰ in healthy young and older adults8,15. However,
it is unknown if inter-limb asymmetry in FPA is a feature of normal gait in adults with DMPN
compared to adults without diabetes. Furthermore, it is also unclear if there is a similar FPA
magnitude in both feet of individuals with DMPN at risk for NPU development. Given the
evidence supporting the link between excessive increased FPA (an FPA of >10±5⁰) and
increased medial PPP in adults with DMPN, we wanted to characterize FPA across a spectrum
of older adults with and without DMPN or a prior history of neuropathic plantar ulceration.
Therefore, the purposes of this study were to describe the magnitude and inter-limb asymmetry
in adults with and without DMPN and a prior history of plantar ulceration. We hypothesized
there would be a progressive increase in FPA magnitude and a progressive decrease in the
inter-limb asymmetry in FPA across a spectrum of participants with and without DMPN and
accompanying history of prior ulceration.
2.3.

Methods

2.3.a. Participants
Forty-five participants with and without diabetes (21 M, 24 F; age, 60±11 yrs; height,
1.7±0.1 m; BMI, 36±8) participated, and provided written informed consent as approved by the
local Institutional Review Board. Participants were classified into one of four groups: 1) agematched non-diabetic control participants (CON), 2) diabetes mellitus without peripheral
neuropathy (DM), 3) diabetes mellitus and peripheral neuropathy without a prior history of a
neuropathic plantar ulcer (DMPN-NPU), and 4) diabetes mellitus and peripheral neuropathy with
a prior history of a neuropathic plantar ulcer (DMPN+NPU). The presence or absence of
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peripheral neuropathy was assigned based on the presence or absence of protective sensation,
and ulcer classification was based on any prior history of plantar ulceration. Peripheral
neuropathy was assessed using a 5.07 (10 gram) Semmes-Weinstein monofilament at seven
sites on the plantar surface of the foot16. In addition, we measured vibration perception
threshold (VPT) using a 120 V bioesthesiometer (Bio-medical Instrument Co., Newbury, OH,
44065, USA) to assess large fiber peripheral nerve function. Those who were unable to
perceive vibration of the bioesthesiometer at threshold of 25 V or greater were classified as
having peripheral neuropathy. A VPT >25 V is associated with incidence of foot ulceration in
individuals with Type 2 diabetes mellitus17. The combination of these tests for protective
sensation has been shown to increase specificity of risk identification and disease severity
without diminution in sensitivity17. Twelve participants were classified as CON, twelve were
classified as DM, eleven were classified as DMPN-NPU, and ten were classified as
DMPN+NPU with 8 reporting a history on one foot and 2 participants reporting a history of
plantar ulcers on both feet (8 unilateral, 2 bilateral). Participants classified as DMPN+NPU did
not have an open ulcer at the time of testing. Those identified as non-ambulatory or with lower
extremity amputations proximal to the digits were excluded from the study.
2.3.b. Gait Analysis
2.3.b.1. Data collection. Three-dimensional kinematic and kinetic data were collected during
gait for the pelvis and bilateral lower extremities while participants walked at a self-selected
speed over a walkway within the capture volume. Kinematic data were acquired using an
infrared 8-camera, 200 Hz motion capture system (Vicon MX, Los Angeles, CA, USA), and
kinetic data were collected using a Bertec K80301 force plate with a resolution of 500 Hz
(Bertec Corporation, Columbus, OH, USA).
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2.3.b.2. Marker placement. All participants were fitted with 10 mm diameter retro-reflective
markers affixed directly to the skin or to pre-molded rigid plate in a non-collinear arrangement to
establish segment coordinate systems for the foot, shank, thigh, pelvis, and trunk. A
modification of the “obesity-specific marker set”, described by Lerner et al for the trunk, pelvis,
and thigh, was used in this study in an effort to account for potential motion artifact secondary to
adiposity18,19. Briefly, single markers for the trunk were placed on the body of the sternum, the
C7 spinous process, right and left acromion processes, and the inferior angle of the scapula.
Markers on the pelvis included single markers on the right and left posterior superior iliac
spines, with an accompanying marker cluster placed on the sacrum. Marker clusters on the
pelvis have been shown to have greater repeatability and less movement variability during nonsagittal plane motion of the pelvis in overweight and obese individuals20. To correct for marker
displacement secondary to adiposity, digitized markers were created for the anterior superior
iliac spines and iliac crests with a static digitizing wand (C-Motion, Germantown, MD) using
procedures described by Lerner et al18,19. Additional corrections were made using
measurements of inter-ASIS distance using a skinfold caliper in subject-specific models. Lerner
et al reported that use of marker clusters and digitized markers on the thigh and pelvis
minimized overestimation of lower extremity kinematics and kinetics19. Single thigh markers
were placed proximally on the greater trochanter and distally on the medial and lateral femoral
epicondyles, with a 4-marker cluster for tracking on the distal thigh superior to the lateral
epicondyle.
We utilized a marker configuration for the foot and shank described by Carson et al
(2001) and modified by Hastings et al (2013). Individual shank markers were placed on the
fibular head, tibial tuberosity, and malleoli, with a 4-marker cluster placed on the distal shank
superior to the lateral malleolus22. To determine FPA magnitude and inter-limb asymmetry, we
modeled the foot as a single, rigid body segment using three markers in a non-collinear
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arrangement. The foot segment was defined by virtual markers created from projected
midpoints between the lateral and medial malleoli at the proximal end, and between the first and
fifth metatarsal heads at the distal end. The hind foot segment was defined by calcaneal marker
placement on the sustentaculum tali, fibular trochlea, and by three mounted markers on a
molded plastic plate applied to the posterior calcaneal bisection—a vertical line between the
sustentaculum tali and the fibular trochlea42. The forefoot segment was defined distally by a
marker placed at the midpoint between the second and third metatarsals, and by markers at the
first and fifth metatarsal heads. The proximal forefoot was defined by the base of the first and
fifth metatarsals. The hallux segment was defined by a plate with three mounted markers
arranged parallel with the long axis of the proximal phalanx of the great toe22.
All participants were asked to walk barefoot at a self-selected speed. All were given at least 1-2
practice trials prior to recording. To minimize risks associated with barefoot walking in
participants in the DMPN-NPU and DMPN+NPU groups, walking distance was truncated to
include the steps on and at least 10 cm beyond the force plate. A maximum of five trials in
which participants were able to contact the force plate without “targeting” were collected. A
minimum of three trials were included in the analysis if FPA values were within one standard
deviation of the within-trial mean for each participant. Stride speed was calculated in the Visual
3D software as the time for the foot opposite the one contacting the force plate to complete one
full stride21.
2.3.c. Data Processing and Analysis.
2.3.c.1. Processing. All marker trajectories and tri-axial force data were processed using a
fourth-order, low-pass filter in Visual 3D software (C-Motion, Inc, Rockville, MD). Marker
trajectories were filtered at 6Hz, and tri-axial force data were filtered at 20Hz. Inter-segmental
and global orientation angles were derived using Cardan angle sequences, and parallel

21

alignment of the segmental axes represent neutral position22. FPA was calculated as the
magnitude of transverse plane rotation of the foot segment around the local superior-inferior
axis at mid stance (i.e., 50% of the stance phase)23.

Kinematic convention for all FPA

measurements was to designate external FPA (toe-out angle) as negative and internal FPA
(toe-in angle) as positive.
2.3.c.2. Statistical analyses. Prior to all analyses, we conducted the Shapiro-Wilk test of
normality to verify that continuous data for both FPA and FPA Diff was normally distributed.
Each foot for all participants was classified as High FPA or Low FPA based on the FPA
magnitude. The foot with the greater FPA was classified as High FPA for all groups, while the
foot with the lesser FPA was classified Low FPA.
Based on previous work investigating asymmetry in lower extremity variables during
gait24,25 we initially performed a two-way analysis of variance (Group [4 levels] X Side [2 levels])
to determine the main and interaction effects of group and side. We then quantified the degree
of inter-limb asymmetry (FPA Diff) as the absolute value of the difference in FPA magnitude
between the High FPA and Low FPA feet (|High-Low|), and performed a univariate analysis of
variance to determine group differences.. Based on previous work8,15, the criterion for having a
clinically meaningful measure of FPA Diff have reported degrees of asymmetry was 4⁰.
Statistical analyses were performed using IBM SPSS Statistics software, version 21.0 (SPSS
Inc, Chicago, IL, USA). Post-hoc analyses for main and interaction effects were conducted
using a Bonferroni correction, with statistical significance for all analyses set at p<.05.
2.4.

Results

2.4.a. Participant Characteristics
The mean (SD) age for all participants (N=45) was 60 (10) years (range: 44-85 years).
There were no group differences in age, height or body mass index (BMI)(Table 2.1). The
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DMPN+NPU group had diabetes for a longer duration and had greater loss of vibration
perception than the DM group (Disease duration in years): DM=8±5, DMPN-NPU=11±9,
DMPN+NPU= 24±8; p<.01). The DMPN-NPU and DMPN+NPU groups had a significantly
greater vibration perception threshold than the DM and CON groups (DMPN+NPU=34 V;
DMPN-NPU=37 V, p<.01). There were no between-group differences in stride speed (p=.80)
(Table 2.1).
2.4.b. FPA magnitude
The DMPN+NPU group had a greater FPA magnitude on the High FPA foot
(DMPN+NPU=-21±5⁰; DMPN-NPU=-13±7⁰; DM=-14±5⁰; CON=-15±6⁰, p=.03), with a trend
toward a greater FPA magnitude in the Low FPA foot compared with the other groups
(DMPN+NPU=-15±6⁰; DMPN-NPU=-9±7⁰; DM=-10±5⁰; CON=-9±5⁰, P=.07). Posthoc testing
showed a greater FPA for the High FPA foot in the DMPN+NPU group compared to the DMPNNPU group (p=.03). Values for the High and Low FPA feet for each group are presented in
Table 2.2. Statistical analysis revealed the presence of outlier values for FPA on both feet in
the control group (CON=-32⁰) and for the DMPN-NPU group (DMPN-NPU=1⁰). Values for FPA
on either foot were considered outliers if they were two or more standard deviations from the
group mean FPA value. Results from analysis with outliers excluded revealed enhanced group
differences in the High FPA foot (DMPN+NPU-21±5⁰; DMPN-NPU=-15±5⁰; DM=-14±5⁰; CON=13±3⁰, p=.01) and Low FPA foot (DMPN+NPU-15±9⁰; DMPN-NPU=-9±4⁰; DM=-10±5⁰; CON=8±3⁰, p=.03). Values for both feet for each group with outliers excluded are shown in Table 2.3.
Time series motion graphs of FPA excursion during the stance phase of gait is illustrated in
Figure 2.1.
2.4.c. FPA asymmetry
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There was a main effect of side, with the High FPA foot having a greater FPA magnitude than
the Low FPA foot (p<.01). There was no interaction effect of group x side (p=.76), which was
confirmed by the lack of FPA Diff between the groups (DMPN+NPU=6±6⁰; DMPN-NPU=5±4⁰;
DM=3±6⁰; CON=6±4⁰, p=.36). When outliers were removed from the analysis, there were no
group differences in FPA Diff. FPA Diff for all groups is shown in Table 2.2.
2.5

Discussion
This is the first investigation to determine the characteristics of FPA in individuals with

and without diabetes mellitus. One of the key findings from this investigation is that external
FPA on the High FPA and Low FPA feet of the DMPN+NPU were greater in magnitude than the
other participant groups. Additionally, there were no between-group differences in inter-limb
asymmetry (FPA Diff).
The FPA values for the High FPA foot of all participant groups were greater than 10⁰,
and would therefore be classified as excessive compared to young adults15. Findings of greater
FPA values in both feet of participants with DMPN with a prior history of ulceration compared
with adults without DM is consistent with previous findings from other research groups5,10.
Hastings et al reported an FPA of greater than 10⁰ in both feet of individuals with DMPN with a
history of ulceration5. This group also stated that FPA magnitude for both feet explained 3545% of the variance in the duration of medial load in adults with DMPN with a prior history of
neuropathic plantar ulceration5. In addition, Mueller et al reported that FPA predicted up to
15% of the variance in medial and lateral forefoot peak plantar pressure on the involved foot of
individuals with DMPN having a prior history of neuropathic plantar ulcers10. These findings
suggest that an excessive FPA in the presence of peripheral neuropathy potentially exposes
individuals with DMPN with a prior history of ulceration to elevated regional peak plantar
pressure sustained for longer duration on the medial side of the foot and subsequently, to an
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elevated risk for NPU development. Therefore, it may be clinically useful to observe and
measure FPA in one or both feet of adults with DMPN with a prior history of ulceration as part of
an assessment of risk for elevated regional stresses and loads that often lead to the
development of new NPUs or recurrent NPUs in the same location on the plantar surface of the
foot. Future studies could identify predictors of FPA magnitude in a cohort of older adults with
and without DMPN.
In the present study, we observed no group differences in FPA inter-limb asymmetry.
These results may indicate that FPA asymmetry in a cohort of adults with and without DMPN is
not disease-specific, and may be a common spatial characteristic of gait in adults 50 years or
older. Several investigators have reported inter-limb differences in movement patterns, force
output, and spatiotemporal parameters as an indicator of disease progression and severity,
though smaller degrees of asymmetry were also reported in groups without pathology 14,25,29-31.
However, there is also evidence to support inter-limb asymmetry in joint alignment and function
as characteristics of normal gait. Sadeghi et al suggest that the cumulative effect of
asymmetries in individual joint function (‘local asymmetry’) possibly culminate into symmetric
performance of the lower extremities during gait (‘global symmetry’)24. Also, Riskowski and
colleagues reported that in population-level study of older adults, greater degrees of asymmetry
in foot alignment were associated with faster walking speeds and more optimal foot function11.
These findings suggest that inter-limb asymmetry of FPA may contribute to optimal gait
performance. Additionally, measurement of the difference in FPA between feet may not be
clinically relevant for the assessment of risk for elevated regional stresses and loads, and
subsequently, the development or recurrence of NPUs in adults with and with DMPN with a prior
history of ulceration.
There are limitations associated with this study. One limitation is the small sample size
of the individual groups. Additionally, our selection criteria for study participation were primarily
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based on disease status, and not on FPA magnitude or inter-limb asymmetry. Refinement of
our selection criteria plus inclusion of additional participants may have potentially resulted in
more robust differences in FPA magnitude. Finally, we selected one of many possible methods
of quantifying asymmetry which we believed was appropriate given the purpose of the study.
The variation in determining inter-limb asymmetry for spatiotemporal gait variables may be
challenging to compare across studies.
2.6.

Conclusion
Results from this investigation highlight the differences in FPA magnitude across a

cohort of adults with and without DMPN and a prior history of ulceration. These findings
suggest that an excessive FPA in the presence of peripheral neuropathy potentially exposes
individuals with DMPN with a prior history of ulceration to elevated regional stresses and loads
on the plantar surface of the foot. Therefore, it may be clinically useful to observe and measure
FPA in one or both feet of adults with DMPN with a prior history of ulceration as part of an
assessment of risk for elevated regional stresses and loads that often lead to the development
of new NPUs or recurrent NPUs in the same location on the plantar surface of the foot.
Findings from this study also suggest that FPA inter-limb asymmetry is not disease-specific, and
may be a common spatial characteristic of walking patterns in adults 50 years or older.
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Age (years)
Height (meters)
Sex (M:F)
BMI (kg/m2)
Disease duration (years)
Great Toe VPT (Volts)
Walking Speed (m/s)
Side of greater FPA (R:L)

CON
(N=12)

DM
(N=12)

DMPN-NPU
(N=11)

DMPN+NPU
(N=10)

p

60 (12)
1.7 (0.1)
7:5
33 (5)†
N/A
20 (9)
1.1 (0.1)
11R:1L

58 (9)
1.7 (0.1)
5:7
34 (8)#
8 (5)#
15 (6)
1.1 (0.1)
9R:3L

63 (11)
1.7 (0.1)
4:7
39 (9)
11 (9)§
37 (11)
1.1 (0.1)
9R:3L

58 (11)
1.7 (0.1)
5:5
41 (9)
24 (8)
34 (17)
1.1 (0.1)
6R:4L

.80
.79
.95
.08
<.01
<.01
.80
--

Table 2.1. Participant characteristics. Values are expressed in mean (SD). VPT: vibration
perception threshold (Volts). Side with greater FPA magnitude (R:L): Number of right feet (R) or
left feet (L). †,#,§ :significance values for between-group differences in participant
characteristics. †: CON versus DMPN-NPU and DMPN+NPU; #: DM versus DMPN-NPU and
DMPN+NPU; §:DMPN-NPU versus DMPN+NPU
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CON
(N=12)
FPA (deg)
FPA Diff

High
-15 (6)*

Low
-9 (5)*

6(4)

DM
(N=12)
High
-14 (5)*

DMPN-NPU
(N=11)

Low
-10 (5)*

3(7)

High
-13 (7)#*
5(4)

Low
-9 (5)*

DMPN+NPU
(N=10)
High
-21 (5)*

Low
-15 (9)*

6(6)

p

.03
.36

Table 2.2. Foot progression angle (FPA) magnitude for each foot for all participants. Values
are expressed in degrees, mean (SD). High: foot with the higher FPA magnitude (High FPA).
Low: foot with the lower FPA magnitude (Low FPA). FPA Diff: the absolute difference in FPA
magnitude between the High FPA and Low FPA feet (|High-Low|). #: Between-group differences
in FPA magnitude of the High foot. DMPN-NPU versus DMPN+NPU. *: Paired mean
differences in FPA for all groups, p<.01.
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CON
(N=12)
FPA (deg)
FPA Diff
(|High-Low|)

High
-13 (3)†*
6(4)

Low
-8 (3)*

DM
(N=12)
High
-14 (5)#*

DMPN-NPU
(N=11)

Low
-10 (5)*

3(6)

High
-15 (5)*

Low
-9 (4)*

5(4)

DMPN+NPU
(N=10)
High
-21 (5)#*

Low
-15 (2)*

6(6)

p

<.01
.40

Table 2.3. Foot progression angle (FPA) magnitude for each foot with outliers excluded from
the analysis. Values are expressed in degrees, mean (SD). High: foot with the higher FPA
magnitude (High FPA). Low: foot with the lower FPA magnitude (Low FPA). FPA Diff: the
absolute difference in FPA magnitude between the High and Low feet. †,#,§ : Between-group
differences in FPA magnitude of the High foot. †: CON versus DMPN+NPU; #: DM versus
DMPU+NPU; §: DMPN-NPU versus DMPN+NPU. *: Paired mean differences in FPA for all
participant groups, p<.01
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Figure 2.1. Time series motion graph of foot progression angle (FPA) during the stance of gait.
The blue line and shaded region represents the mean±1 standard deviation of the motion for the
CON group. Boxed regions represent values used in the analysis. Figure legend. CON: nondiabetic control participants; DM: diabetes mellitus without peripheral neuropathy group; DMPNNPU: diabetes mellitus with peripheral neuropathy without a previous neuropathic plantar ulcer;
DMPN+NPU: diabetes mellitus with peripheral neuropathy with a previous neuropathic plantar
ulcer
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Chapter 3

Static and dynamic predictors of foot progression angle in individuals with diabetes
mellitus and peripheral neuropathy

Status of resulting manuscript: in preparation, Clinical Biomechanics
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3.1

Abstract
The development and recurrence of neuropathic plantar ulcers (NPU) are a significant

health and economic burden worldwide. In the United States, an estimated 12 to 25% of adults
with diabetes mellitus and peripheral neuropathy (DMPN) have a lifetime risk of NPU
development. Foot progression angle (FPA or “toe-out angle”) has been identified as a
predictor of elevated medial and lateral plantar loading in individuals with DMPN. Despite FPA
being reported as a predictor of regional plantar stress in individuals with DMPN, there have
been no identified static or dynamic predictors of FPA magnitude. The primary purpose of this
study was to determine static (goniometric) and dynamic (gait kinematics and kinetics)
predictors of FPA magnitude in adults with DMPN. In a hierarchical multiple regression analysis
of static predictor variables, total hip excursion, ankle dorsiflexion range of motion, and resting
calcaneal stance position (RSCP) accounted for 29% of FPA variance. However, the unique
contribution of these variables was not statistically significant (p>.05). In a hierarchical multiple
regression analysis of the dynamic predictor variables, the overall contribution of all dynamic
predictor variables to FPA was 48%. Thigh and shank external (lateral) rotation accounted for
37% of the variance in FPA (p<.01). These findings suggest that external rotation of proximal
segments during gait better predict FPA than static (goniometric) measures of limited joint
mobility and joint position at the hip, ankle, and subtalar joints in individuals with DMPN.
Identification of dynamic predictors of FPA could inform areas for clinical assessment and
targets for treatment of lower extremity impairments earlier in the lower extremity impairment
cascade to minimize risk of elevated plantar stresses and loads that often lead to NPU
development.

3.2

Introduction
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In the United States, an estimated 15% of patients with diabetes mellitus and peripheral
neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development1,2.
Recent statistics show more than 65,000 non-traumatic lower extremity amputations in adults
with DMPN occur annually in the United States, with 84% preceded by the development of a
NPU3,4. Elevated regional peak plantar pressure is an established index of risk dermal injury in
adults with DMPN6,7, and is thought to initiate a lower extremity impairment cascade of NPU
development and subsequent non-traumatic lower extremity amputation in individuals with
DMPN.
Selected measures of gait performance and of foot and ankle function during gait have
been identified as dynamic (gait kinematic or kinetic) predictors of elevated regional stresses
and loads in adults with DMPN with and without a history of ulcer 6,8,9. Adults with DMPN often
exhibit the following spatiotemporal gait abnormalities: 1) slower gait speed, 2) larger external
foot progression angle (FPA) or ‘toe-out angle’, and 3) prolonged stance time compared with
healthy control participants10-14. Several investigators have reported specific lower extremity
kinematic and kinetic impairments associated with spatiotemporal gait abnormalities in adults
with DMPN. Slower gait speed is associated with decreases in 1st metatarsophalangeal joint
(MTPJ) extension motion, ankle dorsiflexion motion, ankle plantar flexor muscle power, and hip
rotation motion in adults with DMPN compared with healthy control subjects12,15-18. Foot
progression angle is a spatial gait variable defined by the orientation of the longitudinal axis of
the foot in the transverse plane with respect to the direction of gait progression19,20. Studies
from independent groups report external FPA as a dynamic predictor of elevated regional
plantar stresses and loading in individuals with DMPN6,8. However, there is limited available
evidence identifying dynamic predictors of FPA. In studies from pediatric orthopedic literature,
Ho et al suggest that the degree of ankle dorsiflexion motion during gait is related to FPA
magnitude in healthy children21. Lee et al report that inter-segmental external (lateral) rotation
of the pelvis (r=-49, p<.01) and knee (shank to thigh) during gait (r=.38, p=.03) is significantly
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correlated with FPA, whereas hip (thigh to pelvis) is not significantly correlated with FPA in
children with cerebral palsy (r=.33, p=.06)22. Yet it is unknown if these are dynamic predictors of
FPA in individuals with DMPN with and without a history of prior NPU.
Limited joint mobility of the foot and ankle is often measured during clinical assessment
of lower extremity function. Selected goniometric measures of alignment and limited joint
mobility of the foot and ankle have been reported as static predictors of elevated regional peak
plantar pressure in adults with DMPN with and without a history of ulcer23,24. Zimny et al
reported that decreased ankle dorsiflexion and 1st MTPJ extension motions were inversely
correlated with forefoot plantar loads in participants with DMPN without a history of a prior
NPU23. Turner and associates also noted a correlation between 1st MTPJ extension motion and
peak plantar pressure24. Despite the reported impairments in motion and alignment of the 1st
MTPJ and ankle joints as static predictors of elevated plantar stresses and loads, it is unclear if
these impairments predict FPA.
Foot progression angle and selected measures of joint alignment and mobility in the foot
and ankle are static and dynamic predictors of elevated regional plantar stresses and loads in
adults with DMPN. However, there are no reported static or dynamic predictors of external FPA
in individuals with DMPN despite FPA being an established predictor of regional plantar
stresses and loads. Therefore, the purposes of this study were to: 1) determine static and
dynamic predictors of FPA in individuals with and without DMPN, and 2) determine the
between-group differences in select lower extremity static and dynamic measures of foot, ankle,
and hip rotation. We hypothesized that select static and dynamic predictor variables would
explain a significant portion of the variance in FPA. Additionally, we hypothesized a hierarchical
model of dynamic predictor variables would explain a greater portion of FPA variance compared
with a hierarchical regression model of static predictor variables.
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3.3

Methods

3.3. a. Participants
Forty-five participants with and without diabetes (21 M, 24 F; age, 60±11 yrs; height,
1.7±0.1 m; BMI, 36±8) participated, and provided written informed consent as approved by the
local Institutional Review Board. Participants were classified into one of four groups: 1) agematched control (CON), 2) diabetes mellitus without peripheral neuropathy (DM), 3) diabetes
mellitus and peripheral neuropathy without a prior history of a neuropathic plantar ulcer (DMPNNPU), and 4) diabetes mellitus and peripheral neuropathy with a prior history of a neuropathic
plantar ulcer (DMPN+NPU) . The presence or absence of peripheral neuropathy was assigned
based on the presence or absence of protective sensation, and ulcer classification was based
on any prior history of plantar ulceration. Peripheral neuropathy was assessed using a 5.07 (10
gram) Semmes-Weinstein monofilament at seven sites on the plantar surface of the foot25. In
addition, we measured vibration perception threshold (VPT) using a 120 V bioesthesiometer
(Bio-medical Instrument Co., Newbury, OH, 44065, USA) to assess large fiber peripheral nerve
function. Those who were unable to perceive vibration of the bioesthesiometer at threshold of
25 V or greater were classified as having peripheral neuropathy. A VPT >25 V is associated
with incidence of foot ulceration in individuals with Type 2 diabetes mellitus26. The combination
of these tests for protective sensation has been shown to increase specificity of risk
identification and disease severity without diminution in sensitivity26. Twelve participants were
classified as CON, twelve were classified as DM, eleven were classified as DMPN-NPU, and
ten were classified as DMPN+NPU with 8 reporting having had a prior ulcer on one foot and 2
participants reporting having had a prior ulcer on both feet (8 unilateral, 2 bilateral). Participants
classified as DMPN+NPU did not have an open ulcer at the time of testing.
3.3.b. Static predictor measurement
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3.3.b.1. Data collection. Static predictors in this investigation were operationally
defined as goniometric measures of motion and position of select lower extremity joints. Hip
(coxafemoral) joint internal (medial) and external (lateral) rotation were measured using a
bubble inclinometer (Medical Research Ltd, Leeds LS124JF, United Kingdom) with a precision
of 1⁰ using the methods described by Elllison et al (1990)27. Hip rotation was selected for
measurement because of the reported kinematic link between hip rotation and FPA magnitude
in children28,. The reported intra-rater reliability for hip internal and external rotation
measurement using the procedures outlined by Ellison et al ranges from .95-.99 in both
directions in subjects with and without low back pain dysfunction27. Total hip rotation range of
motion is the sum of hip internal (medial) rotation and hip external (lateral) rotation.
Ankle (talocrural) joint dorsiflexion excursion was measured in two positions using a
standard goniometer with a precision of 2⁰, while ankle plantar flexion was measured in the
prone position. Ankle joint dorsiflexion excursion was measured with each participant lying
prone using previously described procedures25. Measurement of ankle joint dorsiflexion
excursion in non-weight bearing is performed with the subtalar joint held in palpated neutral
alignment while the calcaneus moves into dorsiflexion25. Ankle joint dorsiflexion excursion was
also measured in the standing position with the axis of the goniometer aligned with the lateral
malleolus, the moveable arm aligned with the axis of the lateral malleolus and fibular head, and
the stationary arm aligned parallel to the floor. Measurement of ankle joint dorsiflexion in
standing allows for dorsiflexion motion without manual fixation of the talus.

Limited ankle

dorsiflexion motion is reported to contribute to elevated regional plantar pressures and localized
skin breakdown on the plantar surface of the forefoot6,29. The reported intra-rater reliability for
ankle joint ROM measurement using the procedures outlined by Diamond et al (1989) ranges
from .89-.9625.
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First metatarsophalangeal joint (1st MTPJ) extension was measured in sitting with a
standard goniometer using procedures described by Menz et al30. First metatarsophalangeal
joint (1st MTPJ) range of motion was also measured in the standing position with the axis of the
goniometer aligned over the medial aspect of the 1st metatarsal head, the moveable arm aligned
with the first ray, and the stationary arm aligned with the floor.
Calcaneal position in the frontal plane was measured with the participant in the weight
bearing and non-weight bearing positions using a modified procedure described by Picciano et
al (1993)31. For the non-weight bearing measurement of calcaneal frontal plane motion,
participants were in the prone position with the knee of the foot being measured in the extended
position. Using a water-soluble marker, a line of bisection of the lower one-third of the leg was
drawn31. In a similar fashion, a line was drawn between the lateral and medial malleoli
representing a bisection of the calcaneus31. Then, the angle between the lines of bisection on
the lower leg and calcaneus were measured using a standard 2⁰ goniometer31. The axis of the
goniometer was aligned a midpoint between the malleoli, and the stationary and moveable arms
aligned with the line of bisection for the lower leg and calcaneus, respectively31. We also
measured resting calcaneal stance position (RSCP), a weight bearing measurement of
calcaneal position using modified measurement procedures described by Picciano et al31. With
participants in standing, RCSP values represent the alignment of the calcaneus determined as
the angle formed between the lines of the bisection of the posterior calcaneus and the floor
using a standard 2⁰ goniometer31.
3.3.c. Dynamic predictor measurement
3.3.c.1. Data collection. Dynamic predictors in this investigation were operationally defined as
lower extremity segmental and inter-segmental positions and orientations at select points during
the stance phase of gait. Three-dimensional kinematic and kinetic data were collected during
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gait for the trunk, pelvis, and bilateral lower extremities while participants walked at a selfselected speed over a 4 m distance. Kinematic data were acquired using an infrared 8-camera,
200 Hz motion capture system (Vicon MX, Los Angeles, CA, USA), and kinetic data were
collected using a Bertec K80301 force plate with a resolution of 500 Hz (Bertec Corporation,
Columbus, OH, USA).
3.3.c.2. Marker placement. All participants were fitted with 10 mm diameter retro-reflective
markers affixed directly to the skin or to pre-molded rigid plate in a non-collinear arrangement to
establish segment coordinate systems for the foot, shank, thigh, pelvis, and trunk. A
modification of the “obesity-specific marker set”, described by Lerner et al for the trunk, pelvis,
and thigh, was used in this study in an effort to account for potential motion artifact secondary to
central adiposity32,33. Briefly, single markers for the trunk were placed on the body of the
sternum, the C7 cervical spinous process, right and left acromion processes, and the inferior
angle of the right scapula. Markers on the pelvis included single markers on the right and left
posterior superior iliac spines, with an accompanying marker cluster placed on the sacrum.
Marker clusters on the pelvis have been shown to have greater repeatability and less movement
variability during non-sagittal plane motion of the pelvis in overweight and obese individuals34.
To correct for marker displacement secondary to central adiposity, digitized markers were
created for the anterior superior iliac spines and iliac crests with a static digitizing wand (CMotion, Germantown, MD) using procedures described by Lerner et al32,33. Additional
corrections were made using measurements of inter-ASIS distance using skinfold caliper in
subject-specific models. Lerner et al reported that use of marker clusters and digitized markers
on the thigh and pelvis minimized overestimation of lower extremity kinematics and kinetics32.
Single thigh markers were placed proximally on the greater trochanter and distally on the medial
and lateral femoral epicondyles, with a 4-marker cluster for tracking on the distal thigh superior
to the lateral epicondyle.
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We utilized a marker configuration for the foot and shank described by Carson et al35
and modified by Hastings et al36, which included a single, rigid body foot segment36. Individual
shank markers were placed on the fibular head, tibial tuberosity, and malleoli, with a 4-marker
cluster placed on the distal shank superior to the lateral malleolus. The hind foot segment was
defined by calcaneal marker placement on the sustentaculum tali, fibular trochlea, and by three
mounted markers on a molded plastic plate applied to the posterior calcaneal bisection—a
vertical line between the sustentaculum tali and the fibular trochlea36. The forefoot segment
was defined distally by a marker placed at the midpoint between the second and third
metatarsals, and by markers at the first and fifth metatarsal heads. The proximal forefoot was
defined by the base of the first and fifth metatarsals. The hallux segment was defined by a plate
with three mounted markers arranged parallel with the long axis of the proximal phalanx of the
great toe36.
Participants were asked to walk barefoot at a self-selected speed. All were given at
least 1-2 practice trials prior to recording. To minimize risks associated with barefoot walking in
participants in the DMPN-NPU and DMPN+NPU groups, walking distance was truncated to
include the steps on and at least 10 cm beyond the force plate. A minimum of five trials in
which participants were able to contact the force plate without “targeting” was collected. A
minimum of three trials were included in the analysis if values were within one standard
deviation of the within-trial mean for each participant. Walking speed was calculated as stride
length time of the foot contralateral to the limb contacting the force plate36.
3.3.d. Data Processing and Statistical Analysis.
3.3.d.1. Kinematic and kinetic variables. All marker trajectories and tri-axial force data were
processed using a fourth-order, low-pass filter in Visual 3D software (C-Motion, Inc, Rockville,
MD). Marker trajectories were filtered at 6Hz, and tri-axial force data were filtered at 20Hz.
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Inter-segmental and global orientation angles were derived using Cardan angle sequences, and
parallel alignment of the segmental axes represent neutral position36. Foot progression angle
was the value of transverse plane rotation of the foot segment around the local superior-inferior
axis at the mid stance of the gait cycle (i.e., 50% of the stance phase of walking)37.
3.3.d.2. Group comparisons. Prior to all analyses, we conducted the Shapiro-Wilk test of
normality to verify that continuous data for both FPA and all static and dynamic predictor
variables were normally distributed38. Each foot for all participants was classified as either a
High FPA or Low FPA based on the FPA magnitude. The foot with the greater FPA was
classified as High FPA for all groups, while the foot with the lesser FPA was classified Low FPA.
All static and dynamic predictor variables for the High FPA foot were analyzed using a
multivariate analysis of variance (MANOVA) to determine group differences. This analysis was
performed to determine if group assignment should be included into a hierarchical multiple
regression analyses for both static and dynamic predictor variables. Post-hoc analyses were
conducted using a Bonferroni correction, with statistical significance for all analyses set at
p<.05. Statistical analyses were performed using IBM SPSS Statistics software, version 21.0
(SPSS Inc, Chicago, IL, USA).
3.3.d.3. Hierarchical multiple regression analyses. The following hierarchical multiple
regression analyses were conducted, and are summarized below. Variables were considered
predictors of FPA in the multiple regression analyses if they met the following a priori criteria: 1)
the predictor variable had a unique contribution to FPA variance of at least 5%, and 2) the
statistical significance of the change in the overall F value for the coefficients was less than
.056,39.
Hierarchical multiple regression model of static predictors. Because we had no a
priori hypothesis of specific static predictors of FPA, we analyzed the relationship between all
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static predictor variables and FPA on the High FPA foot using Pearson product moment
correlation coefficient (r)6,38 and coefficients of determination (R2). Three of fourteen candidate
static predictor variables plus group predictor variables were selected for inclusion into a
hierarchical multiple regression analysis based on preliminary bivariate correlation and
coefficient of determination analyses. Static predictor variables entered into the model were
total hip rotation range of motion, ankle joint dorsiflexion range of motion in non-weight bearing,
and RSCP. Order for model entry for the static predictor variables was based on the proximal to
distal location of the joint in the lower extremity.
Hierarchical multiple regression model of dynamic predictors. Two hierarchical
multiple regression analyses were performed for the dynamic predictor variables for the High
FPA foot. Predictor variables for the first dynamic hierarchical multiple regression analysis
(Dynamic Model A) were thigh to lab external (lateral) rotation, peak hind foot on shank (ankle)
dorsiflexion, peak hallux on forefoot (1st MTPJ) extension, and peak ankle plantar flexor power.
Dynamic Model A predictor variables were selected a priori based on previously reported
relationships between slower gait speed and limited dynamic forefoot on hind foot (1st MTPJ)
extension, of the hind foot on shank (ankle) dorsiflexion, and decreased ankle plantar flexor
power in adults with DMPN10-14,16. Group variables were also included into the model. Order for
model entry for dynamic predictor variables was based on the proximal to distal location of the
joint in the lower extremity.
To further assess any potential contribution of other candidate dynamic predictor
variables not selected a priori for inclusion into a multiple regression analysis, we performed an
additional hierarchical multiple regression analysis (Dynamic Model B). We analyzed the
relationship between all candidate dynamic predictor variables of FPA on the High FPA foot
using Pearson product moment correlation coefficient (r)6,38 and coefficients of determination
(R2). To determine the unique contributions of inter-segmental foot motion during walking to
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FPA, hind foot on shank (calcaneal) eversion at mid stance as an indicator of frontal plane
subtalar joint position, and forefoot on hind foot abduction at mid stance as an indicator of
transverse plane forefoot position were also included into the multiple regression analysis of
dynamic predictor variables. Selection of these variables was based on previously reported
decreases in frontal plane hind foot motion41, and fixed forefoot deformities (i.e., hammer toe
deformity, hallux abducto-valgus, forefoot abduction on hind foot) in adults with DMPN39,42. The
dynamic predictor variables measured at mid stance included in Dynamic Model B were thigh to
lab external (lateral) rotation, shank to lab external (lateral) rotation, hind foot on shank
(calcaneal) eversion, and forefoot on hind foot abduction. Group variables were also included
into the model. Order for model entry for dynamic predictor variables was based on the
proximal to distal location of the joint in the lower extremity.
3.4.

Results

3.4.a. Participant Characteristics
The mean± SD age for all participants (N=45) was 60±10 years (range: 44-85 years).
There were no group differences in age or height or body mass index (BMI)(Table 3.1). The
DMPN+NPU group had been diagnosed with diabetes earlier and had greater loss of vibration
perception than the DM group. The DMPN-NPU and DMPN+NPU groups had a significantly
greater vibration perception threshold than the DM and CON groups. There were no betweengroup differences in walking speed (p=.80). The mean and standard deviations are shown in
Table 3.1.
3.4.b. Group comparisons
The DMPN+NPU group had a greater FPA on the High FPA foot than the other groups
(DMPN+NPU= -21±5⁰; DMPN-NPU=-13±7⁰; DM=-14±5⁰; CON=-15±6⁰, P=.03). Posthoc testing
revealed a difference between the DMPN-NPU and DMPN+NPU groups (p=.04), as well as a
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trending difference between the DM and DMPN+NPU groups (p=.09). The means and standard
deviations are shown in Table 3.3.
For the static predictor variables, the DMPN+NPU group had less total hip rotation and
standing 1st MTPJ extension range of motion than the other participant groups (DMPN+NPUtotal
hip=

58±17⁰; DMPN-NPUtotal hip= 69±16⁰; DMtotal hip= 80±12⁰; CONtotal hip =77±19⁰, p=.01;

DMPN+NPU 1st MTPJ= 35±18⁰; DMPN-NPU 1st MTPJ = 55±11⁰; DM1st MTPJ = 61±7⁰; CON1st MTPJ
=53±11⁰, p=.01). There were no group differences in range of motion or position for the other
static predictor variables. The means and standard deviations for all static predictor variables
are shown in Table 3.2.
For the dynamic predictor variables, the DMPN+NPU group had less peak ankle plantar
flexor power (p=.01) and peak hallux on forefoot (1st MTPJ) extension during the stance phase
of gait compared to the other participant groups (p=.02). There were no group differences in the
other inter-segmental motion variables. The means and standard deviations for all dynamic
predictor variables are shown in Table 3.3.
3.4.c. Hierarchical multiple regression analyses
Static model. Selection of static predictor variables for inclusion into a hierarchical
multiple regression analysis was based on the results of bivariate correlation and coefficient of
determination analyses for the static predictor variables. The coefficients of determination that
associate static predictor variables with FPA in this model are shown in Table 3.4. Total hip
rotation and ankle dorsiflexion range of motion explained 8-10% of the variance in FPA.
Resting calcaneal stance position (RSCP) explained 6% of FPA variance, a unique contribution
that had a trend toward statistical significance (p=.05), and was therefore included into the
model.
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Table 3.6 illustrates the hierarchical multiple regression model for static predictor
variables. Four variables (total hip rotation range of motion, ankle dorsiflexion range of motion,
RSCP, group) were selected for inclusion into the hierarchical multiple regression model for
static predictor variables. Multiple regression analysis for these four static predictors explain
29% of FPA variance, but the unique contribution of each variable was not statistically
significant (R2=.29, p>.05). Additionally, the group differences in FPA and total hip rotation
range of motion are not significant after the static predictors are partialed out. Based on our
criteria, none of the static predictor variables contribute to FPA variance.
Dynamic model A. Dynamic predictor variables for inclusion into a hierarchical multiple
regression analysis were selected a priori. Table 3.7 illustrates the dynamic multiple regression
analysis of the a priori variables (Dynamic Model A). Multiple regression analysis for the
dynamic predictors explain 37% of FPA variance (R2=.37, p<.05), but the unique contribution of
thigh external (lateral) rotation at mid stance explains 23% of FPA variance (p<.01). The
combined contribution of the remaining predictor variables was 14%, but their unique
contribution to FPA was not significant (p>.05).
Dynamic Model B. The coefficients of determination that associate the dynamic
predictor variables with FPA in this model are shown in Table 3.5. Thigh external (lateral)
rotation and shank external (lateral) rotation at mid stance explained 20-33% of FPA variance.
Table 3.8 illustrates the dynamic multiple regression analysis of the added dynamic predictor
variables. Multiple regression analysis for the dynamic predictors in this model explain 48% of
FPA variance (R2=.48, p<.05). The unique contribution of thigh and shank external (lateral)
rotation at mid stance accounts for 37% of FPA variance (p<.01). Shank to lab external (lateral)
rotation uniquely contributed 16% of FPA variance (R2 change=.16, p=.01). The addition of hind
foot on shank eversion, forefoot on hind foot abduction, and group classification did not predict
FPA.
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3.5

Discussion
This is the first investigation to determine static and dynamic predictors of FPA in a

population of adults with and without DMPN. Additionally, this study is the first to determine the
unique and collective contribution of goniometric measurements of hip rotation to a
spatiotemporal gait variable across a spectrum of individuals with and without diabetes mellitus.
Key findings from this study are that in adults with DMPN, static goniometric measures of lower
extremity alignment and joint mobility do not predict FPA. However, dynamic inter-segmental
external (lateral) rotation of the thigh and shank obtained at the mid stance phase of gait
predicted 37% of variance in FPA in adults with DMPN. Furthermore, inter-segmental foot
motion did not predict FPA in either dynamic hierarchical multiple regression model (Dynamic
Model A, Dynamic Model B).
3.5.a. Static predictors. Static predictors of FPA in the current study are select
goniometric measures of alignment and mobility of select lower extremity joints. One of the
purposes of this study was to identify impairment-based predictor variables that contribute to
FPA at mid stance in participants with and without DMPN and a prior history of ulceration.
Static predictors did not contribute to FPA variance despite limitations in hip rotation and ankle
dorsiflexion in the DMPN+NPU group compared with the other participant groups. These
findings suggest that static measures of alignment and limited joint mobility at the foot and ankle
are not predictive of foot placement during gait in adults with or without DMPN and a prior
history of ulceration. Static measures of limited joint mobility (LJM) are often used to assess
risk for elevated regional plantar stresses and loads in individuals with DMPN23,24. Given the
previously reported relationship between static measures of LJM at the foot and ankle and
elevated regional PPP11,23,24, static measurement of LJM in individuals with DMPN may better
predict regional plantar stresses than FPA.
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3.5.b. Dynamic predictors. In the current investigation, thigh and shank external
(lateral) rotation position at mid stance predicted 37% of the variance in FPA. Shank external
(lateral) rotation position at mid stance was the strongest predictor of FPA, having a unique
contribution of 16% to FPA variance. Furthermore, dynamic measures of inter-segmental foot
mobility, namely hind foot on shank (ankle dorsiflexion, hind foot on forefoot (calcaneal)
eversion, forefoot on hind foot abduction, and hallux on forefoot (1st MTPJ extension) did not
predict FPA in either hierarchical multiple regression analysis. Lee et al reported that knee
(shank on thigh) external rotation during gait was moderately correlated with FPA in children
with cerebral palsy22. Our findings are similar in that external rotation of the thigh and shank
segments best predict FPA in adults with and without DMPN and a prior history of ulceration.
Ho et al reported that healthy children with a large external FPA demonstrated greater ankle
dorsiflexion motion during gait compared with children with “normal” FPA21. In this study, hind
foot on shank (ankle) dorsiflexion motion during gait did not predict FPA in adults with and
without DMPN and a prior history of ulceration. These findings suggest that rotation of the
proximal segments may better predict FPA than distal lower extremity segments in adults with
DMPN. Rao et al reported that dynamic measures of dynamic 1st MTPJ extension accounts for
20% of plantar stresses under the hallux in adults with DMPN43. Although there is considerable
evidence identifying foot motion variables as dynamic predictors of elevated regional plantar
stresses and loads, inter-segmental foot motion variables do not predict FPA.
In the current study, dynamic measures of hind foot on shank (ankle) dorsiflexion, hind
foot on shank (calcaneal) eversion, forefoot on hind foot abduction, and hallux on shank (1st
MTPJ) extension did not predict FPA. A possible explanation could be the moderate to strong
associations of shank external (lateral) rotation with peak ankle plantar flexor power, hind foot
on shank (calcaneal) eversion at mid stance, forefoot on hind foot abduction at mid stance, and
peak hallux on forefoot (1st MTPJ) extension. The association between shank external (lateral)
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rotation and hind foot on shank eversion is illustrative of the coupled motions of shank external
(lateral) rotation with hind foot eversion during the stance phase of gait reported in previous
investigations44-46. Rao et al (2007) reported no differences in segmental motion of the shank
during the stance phase of gait between participants with and without diabetes, which they
suggest augments the differences in hind foot eversion and fore foot sagittal plane motion41.
Findings from the current study suggest that transverse plane motion of the shank at mid stance
is greater in the DMPN+NPU, and is moderately correlated with proximal and distal intersegmental foot motion. The correlation between shank external (lateral) rotation and dynamic
predictor variables manifests as more robust contribution of transverse plane shank motion to
FPA variance.
Interventions that target static and dynamic impairments in foot alignment and motion
structural deformities within the scope of physical therapist practice are limited, and are often
cost prohibitive22. Identifying predictors of FPA could inform areas for clinical assessment and
targets for treatment of lower extremity impairments earlier in the lower extremity impairment
cascade to minimize risk of elevated plantar stresses that often lead to NPU development.
Also, simple cost-effective rehabilitative interventions, like gait modification strategies, which
incorporate movement of proximal lower extremity segments (i.e., the thigh and shank) could be
effective in reducing plantar stresses in areas of the foot vulnerable to ulceration in adults with
DMPN.

Future studies should examine the efficacy of physical therapy interventions such as

gait modification, which may serve as a cost-effective strategy to reducing FPA magnitude, and
subsequently lowering risk for NPU development in adults with DMPN.
There are limitations associated with this study. The first of these limitations is small
sample size using a four-group design. A larger sample size would allow a more thorough
exploration of the many alignment and position variables that might predict FPA magnitude.
Similarly, we did not include radiographic measures in the protocol primarily due to a lack of
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previous indication for their utility in predicting FPA. Given the reported relationship between
radiographic alignment measures of the foot and ankle and elevated regional plantar stresses in
adults with DMPN6,42, static alignment and bony abnormalities of the lower extremity may also
be static predictors of FPA in adults with and without DMPN and a prior history of ulceration.
3.6.

Conclusions
In adults with and without DMPN and a prior history of ulceration, dynamic (gait)

variables best predict FPA. External (lateral) rotation of the proximal segments (thigh and
shank) at the mid stance phase of gait explained 37% of the variance in FPA. Shank external
(lateral) rotation had a unique contribution of 16% to FPA variance, therefore making it the
strongest predictor of FPA. Foot motion variables did not predict FPA in either hierarchical
multiple regression model of dynamic variables, despite group differences in 1st MTPJ extension
and ankle plantar flexor power. Static, goniometric measures of limited joint mobility of the foot
and ankle joints do not predict FPA in individuals with DMPN. These findings suggest that
identifying predictors of FPA could be clinically useful in informing where to focus assessments
and interventions earlier in the lower extremity impairment cascade to minimize risk of elevated
regional plantar stresses and load in adults with DMPN with and without a prior history of
ulceration.
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Age (years)
Height (m)
Sex (M:F)
BMI (kg/m2)
Disease duration (years)
Great Toe VPT (V)
Walking Speed (m/s)
Side of greater FPA (R:L)

CON
(N=12)

DM
(N=12)

DMPN-NPU
(N=11)

DMPN+NPU
(N=10)

p

60 (12)
1.7 (0.1)
7:5
33 (5)†
N/A
20 (9)†
1.1 (0.1)
11R:1L

58 (9)
1.7 (0.1)
5:7
34 (8)#
8 (5)#
15 (6)#
1.1 (0.1)
9R:3L

63 (11)
1.7 (0.1)
4:7
39 (9)
11 (9)§
37 (11)
1.1 (0.1)
9R:3L

58 (11)
1.7 (0.1)
5:5
41 (9)
24 (8)
34 (17)
1.1 (0.1)
6R:4L

.80
.79
.95
.08
<.01
<.01
.80
--

Table 3.1. Participant characteristics, mean (SD). VPT: vibration perception threshold (Volts);
Side of greater FPA (R:L): Number of right feet (R) or left feet (L) having a greater foot
progression angle. †,#,§:significance values for group differences. Disease duration (years): †:
CON versus DMPN-NPU and DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU versus
DMPN+NPU. Great Toe VPT (V): †: CON versus DMPN-NPU and DMPN+NPU; #DM versus
DMPN-NPU and DMPN+NPU;
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Total hip rotation ROM*
Ankle dorsiflexion ROM
RCSP
1st MTPJ extension

CON
(N=12)

DM
(N=12)

DMPN-NPU
(N=11)

DMPN+NPU
(N=10)

p

77 (19)†
8 (5)
4 (2)
53 (11)†

80 (12)#
9 (5)
2 (4)
61 (7)#

69 (16)§
8 (4)
4 (5)
55 (11)§

58 (17)
5 (4)
4 (5)
35 (18)

.01
.20
.78
.01

Table 3.2. Static (goniometric) measures for the foot with the greater foot progression angle
(High FPA). Values are expressed in degrees, mean (SD). Motion variables. Total hip rotation
ROM is the sum of range of motion values for hip internal and external rotation. Ankle
dorsiflexion ROM is goniometric ankle dorsiflexion range of motion measurement in non-weight
bearing (prone lying). Resting calcaneal stance position (RCSP) is measure of calcaneal
position relative to the floor in standing. 1st metatarsophalangeal joint is extension range of
motion measurement assessed in standing. Reported significance values (p) are overall group
comparisons; †,#,§:significance values for group differences. Total hip excursion: †: CON
versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU versus DMPN+NPU. Standing
1st MTPJ extension: †: CON versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU
versus DMPN+NPU
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CON
(N=12)

DM
(N=12)

DMPN-NPU
(N=11)

DMPN+NPU
(N=10)

p

FPA

-15 (6)

-14 (5)

-13 (7)§

-21 (5)

.03

Thigh rotation

-1 (9)

-6 (9)

-4 (13)

-9 (7)

.30

Shank rotation

-4 (13)

-8 (9)

-9 (14)

-16 (8)

.17

9 (5)

9 (5)

8 (5)

13 (3)

.13

†

#

§

1 (1)

.01

-6 (6)

-2 (5)

.22

23 (9)
-5 (8)
1.0 (0.4)

.02
.71
.74

Peak HF on Shank DF
Peak ankle PF power

2 (1)

HF on Shank EV

-7 (9)

Peak hallux on FF EXT
FF on HF ABD
Walking speed (m/s)

†

34 (7)
-6 (7)
1.1 (0.1)

2 (1)

-4 (6)
#

31 (9)
-3 (6)
1.1 (0.1)

2 (1)

§

33 (6)
-3 (9)
1.1 (0.1)

Table 3.3. Dynamic (gait kinematic and kinetic) measures for the foot with the greater foot
progression angle (High FPA). Kinematic values are expressed in degrees, mean (SD). Peak
ankle plantar flexor power is expressed in Watts/kg, mean (SD). Motion variables. FPA is the
foot progression angle on the High FPA foot, (-)=toe-out angle; Thigh rotation: Thigh segment
external rotation (-) value at mid stance; Shank rotation: Shank segment external (-) rotation
value at mid stance; Peak HF on Shank DF: the peak value of hind foot on shank (ankle)
dorsiflexion (+) during stance; Peak ankle PF power: the peak value of ankle plantar flexor
power generation (+) during stance; HF on Shank EV: hind foot on shank (calcaneal) eversion () value at mid stance; Peak hallux on FF EXT: the peak value of hallux on forefoot (1st MTPJ)
extension (+) during stance; FF on HF ABD: forefoot on hind foot abduction (-) at mid stance.
Reported significance values (p) are overall group comparisons. †,#,§:significance values for
group differences. FPA: §: DMPN-NPU versus DMPN+NPU; Peak Ankle PF Power: †: CON
versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU versus DMPN+NPU; Peak
Hallux on FF EXT: †: CON versus DMPN+NPU; #: DM versus DMPN+NPU; §: DMPN-NPU
versus DMPN+NPU
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FPA
Total hip rotation ROM
Ankle dorsiflexion ROM
RSCP
1st MTPJ extension

FPA

Total hip
rotation
ROM

Ankle
dorsiflexion
ROM

RSCP

1st MTPJ
extension

.08*
.10*
.06
.01

.08*
.25**
.00
.18**

.10*
.25**
.00
.02

.06
.00
.00
.00

.01
.18**
.16**
.00
-

Table 3.4. Coefficients of determination (R2) values between the static predictor variables and
foot progression angle (FPA) for the foot with the greater foot progression angle (High FPA).
Motion variables. Total hip rotation ROM is the sum of range of motion values for hip internal
and external rotation. Ankle dorsiflexion ROM is goniometric ankle dorsiflexion range of motion
measurement in non-weight bearing (prone lying). Resting calcaneal stance position (RCSP) is
measure of calcaneal position relative to the floor assessed in standing. 1st
metatarsophalangeal joint is extension range of motion measurement assessed in standing. *:
significance level (1-tailed), p<.05; **: p<.01
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FPA
Thigh
rotation
Shank
rotation
Peak HF on
Shank DF
Peak ankle
PF power
HF on
Shank EV
Peak hallux
on FF EXT
FF on HF
ABD

FPA

Thigh
rotation

Shank
rotation

Peak HF
on
Shank
DF

Peak
ankle
PF
power

HF on
Shank
EV

Peak
hallux on
FF EXT

FF on
HF ABD

-

.45**

.58**

-.26

.32

-.27

.15

.01

.20**

-

.86**

-.22

.37*

-.32*

.32

-.17

.34**

.86**

-

-.23

.40**

-.37*

.33*

-.34*

.07

-.22

-.23

-

-.40**

.21

-.24

-.05

.10

.37*

.40**

-.40**

-

-.36*

.48*

-.05

.07

-.32*

-.37*

.21

-.36*

-

-28

-.01

.02

.32

.33*

-.24

.48*

-28

-

-.29

.00

-.17

-.34*

-.05

-.05

-.01

-.29

-

Table 3.5. Coefficients of determination (R2) values between the dynamic predictor variables
and foot progression angle (FPA) for the foot with the greater foot progression angle (High
FPA).

Motion variables. FPA: the foot progression angle on the High FPA foot, (-)=toe-out

angle; Thigh rotation: Thigh segment external rotation (-) value at mid stance; Shank rotation:
Shank segment external (-) rotation value at mid stance; Peak HF on Shank DF: the peak value
of hind foot on shank (ankle) dorsiflexion (+) during stance; Peak ankle PF power: the peak
value of ankle plantar flexor power generation (+) during stance; HF on Shank EV: hind foot on
shank (calcaneal) eversion (-) value at mid stance; Peak hallux on FF EXT: the peak value of
hallux on forefoot (1st MTPJ) extension during stance; FF on HF ABD: forefoot on hind foot
abduction (-) at mid stance.
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Variables
(Constant)
Total hip rotation ROM
Ankle dorsiflexion ROM
RSCP
d1 (DM)
d2 (DMPN-NPU)
d3 (DMPN+NPU)

Unstandardized
beta
(95% CI)
-18.73
(-30.52,-15.00)
.03
(-.09, .15)
.15
(-.22, .52)
-.41
(-.91, .09)
.38
(-4.67, 5.42)
2.55
(-2.89, 7.99)

Standardized
beta

R2

R2
change

Sig. F
Change

N/A

N/A

N/A

<.01

.09

.08

.08

.07

.13

.12

.04

.18

-.25

.18

.06

.10

.29

.11

.15

.03
.17

-4.02
(-10.04, 1.99)

-.27

Table 3.6. Hierarchical multiple regression analysis of static (goniometric) predictors of foot
progression angle (FPA) on the foot with the greater FPA (High FPA). Variables are listed in the
order of entry. Motion variables. Total hip rotation ROM is the sum of range of motion values
for hip internal and external rotation. Ankle dorsiflexion ROM is goniometric ankle dorsiflexion
range of motion measurement in non-weight bearing (prone lying). Resting calcaneal stance
position (RCSP) is measure of calcaneal position relative to the floor assessed in standing. 1st
metatarsophalangeal joint is extension range of motion measurement assessed in standing.
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Variables
(Constant)
Thigh rotation
Peak HF on Shank DF
Peak hallux on FF EXT
Peak ankle PF power
d1 (DM)
d2 (DMPN-NPU)
d3 (DMPN+NPU)

Unstandardized
beta
(95% CI)
-15.47
(-26.01,-4.80)
.24
(.06, .45)
-.02
(-.52, .30)
.04
(-.15, .88)
.08
(-2.14, 3.39)
1.92
(-2.89, 6.74)
2.58
(-2.26, 7.41)

Standardized
beta

R2

R2
change

Sig. F
Change

N/A

N/A

N/A

<.01

.37

.23*

.23

<.01

-.08

.25

.05

.26

.05

.26

.03

.45

.19

.29

.03

.25

.37

.08

.30

.14
.18

-3.01
(-8.85, 2.83)

-.20

Table 3.7. Hierarchical multiple regression analysis of dynamic (gait kinematic and kinetic)
predictors of foot progression angle (FPA) on the High FPA foot (Dynamic Model A). Variables
are listed in the order of entry. Motion variables. Thigh rotation: Thigh segment external
rotation (-) value at mid stance; Peak HF on Shank DF: the peak value of hind foot on shank
(ankle) dorsiflexion (+) during stance; Peak hallux on FF EXT: the peak value of hallux on
forefoot (1st MTPJ) extension (+) during stance; Peak ankle PF power: the peak value of ankle
plantar flexor power generation (+) during stance. d1,d2,d3: Coding for group classification with
CON participants as the reference group. d1: DM group; d2: DMPN-NPU group; d3:
DMPN+NPU group
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Variables
(Constant)
Thigh rotation
Shank rotation
HF on Shank EV
FF on HF ABD
d1 (DM)
d2 (DMPN-NPU)
d3 (DMPN+NPU)

Unstandardized
beta
(95% CI)
-13.63
(-15.0,-12.2)
-.15
(.46, .16)
.40
(.10, .70)
-.10
(-.16, .29)
.06
(-1.45, 7.05)
1.62
(-2.60, 5.84)
2.80
(-1.45, 7.05)

Standardized beta

R2

R2
change

Sig. F
Change

N/A

N/A

N/A

<.01

-.24

.21*

.23

<.01

.75

.37*

.16

<.01

-.11

.39

.05

.32

.08

.41

.03

.26

.48

.07

.20

.12
.20

-1.84
(-6.48, 2.79)

-.13

Table 3.8. Hierarchical multiple regression analysis of dynamic (gait kinematic and kinetic)
predictors of foot progression angle (FPA) on the High FPA foot (Dynamic Model B). Variables
are listed in the order they were entered into the multiple regression analysis. Motion
variables. Thigh rotation: Thigh segment external rotation (-) value at mid stance; Shank
rotation: Shank segment external (-) rotation value at mid stance; HF on Shank EV: hind foot on
shank (calcaneal) eversion (-) value at mid stance; FF on HF ABD: forefoot on hind foot
abduction (-) at mid stance. d1,d2,d3: Coding for group classification with CON participants as
the reference group. d1: DM group; d2: DMPN-NPU group; d3: DMPN+NPU group
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B.

A . FPA

C. Shank rotation

E.

Ankle PF Power

Thigh rotation

D.

HF on Shank (ankle)

F.

Hallux on FF (1st MTPJ)

H. FF on HF (forefoot)

G. HF on Shank (calcaneal)

64

Figure 3.1. Time series motion graphs of dynamic predictor variables during the stance of
walking. The blue line and shaded region represents the mean± 1 standard deviation of the
motion for the CON group. Boxed regions represent values used in the analysis. Figure
legend. CON: non-diabetic control participants; DM: diabetes mellitus without peripheral
neuropathy group; DMPN-NPU: diabetes mellitus with peripheral neuropathy without a previous
neuropathic plantar ulcer; DMPN+NPU: diabetes mellitus with peripheral neuropathy with a
previous neuropathic plantar ulcer. Motion variables. A. FPA: FPA on the High FPA foot ()=toe-out angle; B. Thigh rotation: Thigh segment internal (+)/external rotation (-) ; Shank
rotation: C. Shank segment internal(+)/external(-) rotation; D. HF on Shank (ankle): Hind foot
on shank (ankle) dorsiflexion (+)/plantarflexion (-); E. Ankle PF power: Ankle plantar flexor
power generation (+)/absorption(-); F. Hallux on forefoot (1st MTPJ) extension (+)/flexion (-); G.
HF on Shank (calcaneal): Hind foot on shank inversion (+)/eversion (-); H. FF on HF (forefoot):
Forefoot on hind foot adduction (+)/abduction (-).
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Chapter 4

Impact of foot progression angle modification on plantar loading in individuals
with diabetes mellitus and peripheral neuropathy

Status of resulting manuscript: in preparation, Gait & Posture
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4.1.

Abstract

In the United States, an estimated 12 to 25% of patients with diabetes mellitus and peripheral
neuropathy (DMPN) have a lifetime risk of neuropathic plantar ulcer (NPU) development. Peak
plantar pressure (PPP) is often used as an index of risk for NPU development in individuals with
DMPN. Previous groups have reported a direct relationship between an excessive external foot
progression angle (FPA) and the magnitude of regional PPP in adults with DMPN. However, it
is unknown if FPA is modifiable in diabetes mellitus, or the effects of such a modification on
regional PPP. The purposes of this study were to determine: 1) if participants with diabetes
mellitus can reduce FPA, and 2) the impact of the reduction of FPA on the magnitude of PPP.
Twenty-one individuals with diabetes were classified as having: 1) diabetes mellitus without
peripheral neuropathy (DM), and 2) DMPN with a prior history of NPU (DMPN+NPU).
Participants walked at their preferred FPA (pFPA), and with their foot in a corrected, or reduced,
FPA position (cFPA). The cFPA was reduced from the pFPA in both groups, but only significant
for the DM group (Mean±SE; DMpFPA=-13±2⁰, DMcFPA=4±3⁰, p=<.01; DMPN+NPUpFPA=-16±2⁰;
DMPN+NPUcFPA=-11±4⁰, p=.13). The DM group demonstrated a 32% reduction in medial
forefoot PPP in the cFPA versus the pFPA condition that trended toward statistical significance
(Mean±SE; DMpFPA=44±11 N/cm2, DM=30±14 N/cm2, p=.07). Our findings highlight the
potential utility for FPA modification in adults with diabetes mellitus as a therapeutic intervention
for offloading areas of the foot at risk for NPU development.
4.2.

Introduction

The development and recurrence of neuropathic plantar ulcers (NPUs) are a significant
health and economic burden worldwide. In the United States, an estimated 12 to 25% of
individuals with diabetes mellitus and peripheral neuropathy (DMPN) have a lifetime risk of NPU
development1,2. Previous studies have shown that individuals with DMPN with history of NPU
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have greater peak plantar pressure (PPP) in the forefoot region compared to those who did
not3,4. Those with a history of NPU have the highest relative risk for re-ulceration of the
previous healed NPU or ulcer development in an alternative location (RR=2.46; 95% CI: 1.843.29)5 Over 65,000 non-traumatic lower extremity amputations in adults with DMPN are
performed annually in the United States, 84% of which are preceded by NPUs6,7.
Numerous treatment strategies have been employed for offloading plantar sites to promote
NPU healing and to prevent re-ulceration. Commonly used offloading strategies include use of
custom-made insoles or other shoe modifications8, removable cast walking boots, total contact
casting, and non-weight bearing strategies such as wheelchair usage9. Though custom made
insoles, total contact casts, and removable cast walking boots have been shown to successfully
reduce forefoot and mid foot peak plantar pressure in individuals with DMPN and a history of
NPU 8,10, there are often barriers related to cost, patient compliance, and reimbursement 9,11.
Much of the previous research reports the efficacy of these interventions as treatment strategies
for healing existing NPUs12. Moreover, non-weight bearing offloading techniques potentially
contribute to the development and progression of mobility limitations reported by individuals with
diabetes6. Though offloading strategies may provide the proper healing environment for NPUs,
extensive periods of offloading may make the skin on the plantar surface of the foot vulnerable
to re-injury, as evidenced by the high rates of re-ulceration (~20-70%) after successful healing
with offloading13,14.
In addition to casting, orthotics, and footwear treatment options, researchers have also
examined the effectiveness of modifying gait patterns on reduction of PPP in healthy young
adults and in adults with DMPN11,15,16. Gait modification strategies for older adults with DMPN
include walking slower, reducing push off in late stance phase of walking by exaggerating hip
flexion15, or walking with a “step-to” gait pattern16. Though these strategies reduce PPP in the
forefoot, reported changes in other regions of the plantar surface of the foot are variable15,16.
Foot progression angle (FPA), or “toe-out angle,” is the orientation of the longitudinal axis of the
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foot in the transverse plane with respect to the direction of progression during gait17,18.
Investigators have reported a direct relationship between excessive external FPA and elevated
medial PPP in children with neurological impairments, and with the timing and magnitude of
medial and lateral PPP in adults with DMPN19-21. However, there have been no reports as to
whether an excessive FPA is modifiable in individuals with diabetes mellitus with or without
peripheral neuropathy, or the effects of such a modification on regional PPP. Therefore, the
purposes of this study were to: 1) determine if participants with diabetes mellitus with and
without peripheral neuropathy and a history of NPU can reduce their excessive FPA with a
simple intervention of verbal and visual cueing, and 2) determine the impact of FPA reduction
on regional PPPs in adults with diabetes. We hypothesized that reduction of FPA in both
groups would result in concomitant decreases in the magnitude of PPP on the medial forefoot
mask on the plantar surface of the foot.

4.3.

Methods

4.3.a. Subjects
Twenty-one individuals with diabetes (10 men, 11 women; Mean±SE; age, 59±2.0 years;
height, 1.7±0.1 m; BMI, 37±2 kg/m2) participated, and provided written informed consent as
approved by our university’s Institutional Review Board. Participants were classified into one of
two groups: 1) diabetes mellitus without peripheral neuropathy (DM), and 2) diabetes mellitus
and peripheral neuropathy with a prior history of a neuropathic plantar ulcer (DMPN+NPU). The
purpose for selecting these groups was to determine the effect of reducing FPA in a population
of adults with diabetes that demonstrated mild and severe impairment in sensation and foot
function. The presence or absence of peripheral neuropathy was assigned based on the
presence or absence of protective sensation, and ulcer classification was based on any prior
history of plantar ulceration. Peripheral neuropathy was assessed using a 5.07 (10 gram)
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Semmes-Weinstein monofilament at seven sites on the plantar surface of the foot22. In addition,
we measured vibration perception threshold (VPT) using a 120 V bioesthesiometer (Bio-medical
Instrument Co., Newbury, OH, 44065, USA) to assess large fiber peripheral nerve function.
Those who were either unable to feel the 10 gram monofilament on at least one of the seven
sites on the foot, or were unable to perceive vibration of the bioesthesiometer at threshold of 25
V or greater were classified as having peripheral neuropathy. A VPT >25 V is associated with
incidence of foot ulceration in individuals with Type 2 diabetes mellitus23. The combination of
these tests for protective sensation has been shown to increase specificity of risk identification
and disease severity without diminution in sensitivity23. Eleven participants were classified as
DM, and ten were classified as DMPN+NPU. Of the DMPN+NPU participants, 8 reported a
history of unilateral ulceration and 2 reported a history of bilateral ulceration. Participants
classified as DMPN+NPU were not ulcerated at the time of testing. Those identified as nonambulatory or with lower extremity amputations proximal to the digits were excluded from the
study.
4.3.b. Procedure
Dynamic plantar pressures were collected using an EMED-ST-P-2 pedobarograph
(Novel Inc., St. Paul, MN, USA). System specifications include a sampling frequency of 50Hz
and resolution of 2 sensors/cm2 for a network of 2736 sensors. Participants were selected to
walk under two conditions using the 2-step method 24. Participants were first asked to walk over
a 3.6 m walkway at their self-selected speed and preferred FPA (pFPA). Participants were
then verbally directed to align their foot along the 2nd ray (representing the longitudinal axis of
the foot) on a thickened black line in the floor parallel with the line of gait progression and walk
with their foot in this corrected position (cFPA) over the walkway their self-selected speed.
Participants were also given verbal instructions to “keep their feet turned straight” prior to
practice trials. Walking speed was measured using a stopwatch over a predetermined distance,
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and is expressed in meters/min. Participants performed three walking trials with each foot
contacting the EMED platform during each condition. All participants were allowed 1-2 practice
trials prior to recording.
4.3.c. Data processing and statistical analysis
4.3.c.1. FPA measurement. FPA was calculated as measured angle between the line
of progression (a line drawn parallel to the printed paper) and the line representing the anteriorposterior bisection of the foot extending from the center of the hind foot through the 2nd/3rd rays
obtained from the plantar pressure map using a 2⁰ increment goniometer20. A change of ≥4⁰
was considered a meaningful corrected change in FPA based on reported ranges of 5-9⁰ for
FPA magnitude and 1-2⁰ for FPA asymmetry in young and older adults25. The threshold of ≥4⁰
was, therefore, the desired response to visual and verbal cues with several practice trials.
4.3.c.2. Masks of Pressure map. The pressure map of each foot step was first divided
into two regions using a 50% vertical bisector approximately between the 2nd and 3rd rays,
creating medial (Med) and lateral (Lat) vertical masks using Percent Mask software (Novel Inc.,
St. Paul, MN, USA). The plantar map was further divided into three horizontal regions at 33%
and 63% of foot length creating masks at the heel (Heel), mid foot (Mid) and forefoot (Fore).
The vertical and horizontal bisections of the foot created six distinct masks: the medial and
lateral forefoot (Med Fore, Lat Fore), the medial and lateral mid foot (Med Mid, Lat Mid), and the
medial and lateral heel (Med Heel, Lat Heel). The variable of interest was peak plantar
pressure (PPP) which we use to operationally define stress based on previous work8. PPP is
the peak pressure recorded within a mask region during stance phase of the gait cycle8. PPP
has been accepted as an index of risk for dermal injury on the foot plantar surface because
elevated regional PPP values occur at areas of skin breakdown in individuals with diabetes that
have a lack of protective sensation and a history of neuropathic ulceration19. Force-time integral
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(FTI) is a description of force expressed as a calculated sum of the product of pressure
recorded from each sensor multiplied by the area and contact time of each sensor (∑(pressure
X area X time)) for each region of the plantar surface of the foot8
4.3.c.3. Statistical analysis. Participants’ feet were designated as Involved (Inv) for
the DMPN+NPU group based on the foot with an ulcer history. If DMPN+NPU participants had
a history of bilateral involvement, the foot with the most recent ulceration was classified as the
Inv foot. Comparisons were made between the Inv foot of the DMPN+NPU group and a
randomly assigned foot of participants in the DM group. Statistical analyses were performed
using IBM SPSS Statistics software, version 21.0 (SPSS Inc, Chicago, IL, USA).
PPP and FTI for the Inv foot was averaged over three trials, and statistically analyzed
using a repeated measures, mixed-model analysis of covariance (ANCOVA). There was no
difference in walking speed between conditions for either group, but there was a between-group
difference in walking speed for both conditions. Therefore, an average walking speed (mean
walking speed=49 m/min) was used as a covariate to account for the established influence of
walking speed on PPP as well as the between-group differences in walking speed (Table 1)26.
The between-groups factor was group (DM versus DMPN+NPU), and the repeated measures
factors were condition (pFPA versus cFPA), mediolateral mask location (Mask A: Lat versus
Med), and anteroposterior mask location (Mask B: Fore versus Mid). Only the forefoot and mid
foot masks were included in the analyses because these regions are most vulnerable to NPU
development11,27. Post-hoc analyses for main and interaction effects were conducted using a
Bonferroni correction, with statistical significance for all analyses set at p<.05.
4.4.

Results

4.4.a. Participant Characteristics
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The mean ± SE age for all participants (N=21) was 59±2 years (range: 43-76 years).
There were no group differences in age, DM, height, or body mass index (BMI) (Table 1). The
DMPN+NPU group had a longer duration of diabetes and greater vibration perception threshold
(VPT) on the Inv foot than the DM group, confirming the presence of peripheral neuropathy.
There were between-group differences in walking speed, with the DM group walking faster than
the DMPN+NPU group under both conditions (Table 4.1).

4.4.b. Foot Progression Angle
The DM group showed a significant reduction in FPA between conditions (Mean±SE;
pFPA=-13±2⁰, cFPA=4±3⁰; p<.01). Though the DMPN+NPU group overall achieved the
meaningful corrected change in FPA magnitude of at least 4⁰, the reduction in FPA was not
statistically significant (pFPA=-16±2⁰, cFPA=-11±4⁰; p=.13). Nine participants out of eleven
(82%) in the DM group and seven of ten participants (70%) in the DMPN+NPU group were able
to achieve the meaningful corrected change in FPA magnitude. Two of eleven participants
(18%) in the DM group and five of ten participants (50%) in the DMPN+NPU had a FPA of ≥10⁰
in the cFPA condition. Of the five DMPN+NPU participants with an FPA of ≥10⁰ in the cFPA
condition, three of them did not achieve the meaningful corrected change of 4⁰. There were
participants in both groups that demonstrated reductions in FPA that resulted in the
development of an internal FPA (“toe-in” angle), a positive numeric value. The DM group had a
greater magnitude of absolute change between conditions compared to the DMPN(+)NPU
group, but these differences were not statistically significant (DM: 16±3⁰, DMPN+NPU: 9±2⁰,
p=.14). Values are shown in Table 4.2.

4.4.c. Peak Plantar Pressure
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Values for PPP in each mask region are in Table 4.3. There was a statistically significant
four-way interaction of Condition x Group x Mask A (Lat versus Med) x Mask B (Fore versus
Mid) (p=.0.02). Figure 4.1 illustrates the peak plantar pressure profiles for the DM and
DMPN+NPU groups. DM participants reduced PPP in the medial forefoot and increased PPP in
the lateral mid foot in the cFPA condition compared with the pFPA condition. The DMPN+NPU
group showed very little change in pressure in any region as a function of FPA correction. Post
hoc comparisons verified this pattern, albeit only at marginally significant levels. There was a
32% decrease in the Med Fore mask in the DM group (pFPA=44 N/cm2, cFPA=30 N/cm2;
p=.07), with an accompanying 62% increase in the Lat Mid mask (pFPA=21 N/cm2, cFPA=35
N/cm2; p=.07). Regional changes in PPP in the DM group demonstrated trends toward
statistical significance.

4.4.d. Force-Time Integral
There was a significant Condition X Mask B interaction (Fore versus Mid, p=.04). There
was a decrease in FTI in the forefoot from the pFPA to the cFPA condition (pFPA=139 N/cm2,
cFPA=130 N/cm2, p=.02), with an increase in FTI in the mid foot (pFPA=68 N/cm2, cFPA=76
N/cm2, p=.01). No other effects were statistically significant. Values are shown in Table 4.4.

4.5.

Discussion
This is the first investigation to determine the impact of FPA modification on plantar

loading in participants with diabetes with and without peripheral neuropathy and plantar
ulceration. One of the key findings from this investigation was that both groups overall achieved
a clinically meaningful reduction of at least 4⁰ in their FPA with visual and verbal cueing.
Another key finding was that both groups had a characteristic pressure shift from the medial
forefoot (Med Fore) mask, a region shown to be at risk for ulceration in adults with DMPN, to the
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lateral mid foot (Lat Mid) mask as a result of the reduction in FPA. However, larger differences
in PPP were observed in the DM group. These findings indicate that use of a simple gait
modification strategy of reducing FPA may be a potentially effective therapeutic strategy to
modify plantar stresses in areas of the foot vulnerable to dermal injury in adults with diabetes
mellitus prior to the onset of peripheral neuropathy and the development of a neuropathic
plantar ulcer.
In the current study, we observed a pattern of reduction in medial forefoot PPP
(DM=32%; DMPN+NPU=8%), with a notable increase in lateral mid foot PPP in both groups
(DM=62%; DMPN+NPU=21%). Other research groups have reported similar patterns of
reduction in forefoot PPP using various gait modification strategies. Mueller and colleagues
have reported reductions in in-shoe forefoot PPP by 27-53% and increases in heel PPP by 24%
using “hip flexion” and “step-to” gait modification strategies15,16. The authors, however,
acknowledge these types of gait modifications impair movement symmetry and gait speed.
Rosenbaum (2013) reported that manipulation of FPA yielded a 54% decrease in medial
forefoot PPP and a 75% increase in lateral mid foot PPP as a result of in-toeing28. The current
investigation expands these findings by investigating the effects of implementing a similar gait
modification in participants with diabetes with and without peripheral neuropathy. In our study,
both groups experienced a shift in PPP from the medial forefoot to the lateral mid foot, though
participants in the DM groups had a greater magnitude of these changes compared to the
DMPN+NPU group. The differences in the magnitude of the regional changes in PPP between
groups could be attributed to limitations in hip and ankle range of motion29,30. Additionally, the
increase in regional PPP in the lateral mid foot in both groups were well below PPP values
reported by Sinacore et al (2008) for classifications of lateral column foot deformities in
individuals with DMPN27.
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In recent years, there has been an expansion in the number of treatment options for
offloading areas of the foot vulnerable to NPU development in individuals with DMPN. In a
review by Bus et al (2008), there is evidence supporting the efficacy of custom made insoles,
total contact casts, and removable cast walkers for reducing forefoot PPP compared to standard
footwear. Percentages of reduction in forefoot PPP range from 10-19% for custom made
insoles13. In the current investigation, we observed greater reductions in medial forefoot PPP
using FPA reduction as a gait modification strategy. Findings from this investigation
demonstrate the potential for achieving similar decreases in areas of the foot vulnerable to
dermal injury in adults with diabetes using a movement strategy as a cost-effective therapeutic
intervention within the scope of physical therapist practice.
One of the limitations associated with this study is the small sample size. Inclusion of
additional participants would have potentially brought the trending differences in the lateral mid
foot to statistical significance. Another limitation is the heterogeneity of reported NPU location in
the DMPN+NPU group. Ulcer location may be indicative of the onset of rigid structural foot
deformities, thereby potentially limiting the magnitude of PPP reductions in the regions of
interest. In addition, FPA modification consisted of single session instruction, with
measurements taken over several single steps. Future studies could expand these findings by
assessing the effects of changing FPA over multiple steps, and determining the effects of
modifying FPA on other parts of the lower extremity kinetic chain. Finally, we examined the
effect of modifying FPA under barefoot conditions to observed changes in PPP without the
influence of footwear. Therefore, we cannot generalize these findings to the effect of FPA
modification to in-shoe pressure measurements. Future studies should confirm the impact of
this type of gait modification strategy on in-shoe measurements of PPP.
4.6.

Conclusion
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Our findings highlight the potential utility for FPA modification in adults with diabetes
mellitus as a therapeutic intervention aimed at offloading areas of the plantar surface of the foot
at risk for NPU development. Furthermore, we were able to reduce medial forefoot loading
without creating excessive loads in other regions of the forefoot and mid foot. Therefore, using
FPA reduction as a treatment strategy for offloading areas of the foot at risk for NPU
development could be safely implemented in a physical therapist clinical practice.
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Age (years)
Height (m)
BMI (kg/m2)
Duration of disease (years)
R Great Toe VPT (volts)
Walking speed (m/min)

DM (N=11)
Mean (SE)
59 (3)
1.7 (0.1)
34 (3)
7 (2)*
15 (4)*
58 (2)*

DMPN+NPU (N=10)
Mean (SE)
58 (3)
1.7 (0.1)
40 (3)
24 (2)
34 (4)
38 (3)

p
.80
.70
.09
<.01
<.01
<.01

Table 4.1. Participant characteristics, mean (SE). VPT: vibration perception threshold
(Volts); participants with a VPT greater than 25 Volts. *:p<.05
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Preferred FPA (pFPA, deg)
Corrected FPA (cFPA, deg)
FPA change (deg)
# able to correct >4⁰
#with ≥10⁰ cFPA

DM
(N=11)

DMPN+NPU
(N=10)

p

-13 (2)
4 (3)
16 (3)
9
2

-16 (2)
-11 (4)
9 (2)
7
5

.15
<.01
.14
---

Table 4.2. Foot progression angle (FPA) magnitude on the involved (Inv) foot in both
conditions for both groups. Values are expressed in degrees, mean (SE). Absolute
FPA change (deg): the absolute difference in FPA between conditions on the involved
(Inv) foot; #able to correct: the number of participants able to achieve a clinically
meaningful corrected change in FPA; # with ≥10⁰ in cFPA condition: the number of
participants with an FPA ≥10⁰ for the cFPA condition.

82

Group

pFPA

cFPA

p
(condition)

95% CI
(Mean
difference)

Mean (SE)

Mean (SE)

DM
DMPN+NPU
p (Group)

58 (2)*
39 (5)
<.01

57 (2)*
38 (4)
<.01

.32
.58

-2 to 4
-3 to 6

DM
DMPN+NPU
p (Group)

-13 (2)*
-16 (2)
.15

4 (3)*
-11(4)
<.01

<.01
.13

-23 to -10
-13 to 2

16 (3)
9 (2)
.14

N/A
N/A

44 (11)
64 (9)
.16

30 (14)
59 (11)
.12

.07
.24

-2 to 30
-7 to 18

36 (10)
60 (8)
.08

30 (10)*
57 (8)
.04

.37
.57

-5 to 17
-6 to 11

10 (1)
8 (1)
.39

10 (6)
11 (5)
.88

.99
.55

-12 to 12
-12 to 7

21(10)
26 (8)
.74

35 (12)
31 (10)
.83

.07
.32

-28 to 1
-17 to 6

Walking Speed
(m/min)

FPA (deg)

Absolute FPA
change (deg)
DM
DMPN+NPU
p (Group)
PPP Med Fore (N/cm2)
DM
DMPN+NPU
p (Group)
PPP Lat Fore (N/cm2)
DM
DMPN+NPU
p (Group)
PPP Med Mid (N/cm2)
DM
DMPN+NPU
p (Group)
PPP Lat Mid (N/cm2)
DM
DMPN+NPU
p (Group)

-2 to 15
-2 to 14

Table 4.3. Foot progression angle (FPA) and peak plantar pressure (PPP) covariancecorrected means for the four-way interaction effect of Condition (pFPA versus cFPA) x Group
(DM versus DMPN+NPU) x Mask A (Fore versus Mid) x Mask B (Lat versus Med) (p=.0.02).
Columns represent the condition effect (within-group differences) in all variables, expressed in
mean (SE). Rows represent the group effect (between-group difference) in all variables,
expressed in mean (SE). pFPA: preferred FPA walking condition; cFPA: corrected FPA walking
condition. Mask descriptions. Med Fore=medial forefoot; Lat Fore=lateral forefoot; Med
Mid=medial mid foot; Lat Mid=lateral mid foot. Variable descriptions. FPA: the value of foot
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progression angle on the involved (Inv) foot for both groups under both walking conditions.
Absolute FPA change: Absolute difference in FPA between conditions on the involved (Inv) foot.
PPP: peak plantar pressure for each mask.

p (condition): significance values for the condition

main effect, 95% CI of the average difference. p (group): significance values for the group main
effect, p<.05.
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Group

FTI Med Fore (N*s)
DM
DMPN+NPU
p (group)
FTI Lat Fore (N*s)
DM
DMPN+NPU
p (group)
FTI Med Mid (N*s)
DM
DMPN+NPU
p (group)
FTI Lat Mid (N*s)
DM
DMPN+NPU
p (group)

pFPA

cFPA

p value
(condition)

95% CI
(Mean
difference)

Mean (SE)

Mean (SE)

138 (42)
189 (33)
.35

119 (40)
181(31)
.24

.86
.54

-15 to 53
-19 to 18

93 (22)
136 (17)
.15

94 (21)
128 (16)
.20

.98
.54

-33 to 32
-18 to 33

14 (8)
9 (6)
.60

17 (19)
21 (15)
.89

.87
.45

-44 to 38
-44 to 20

116 (37)
133 (29)
.35

128 (35)
138 (28)
.23

.48
.32

-47 to 23
-17 to 6

Table 4.4. Force-time integral (FTI) covariance-corrected means for the four-way interaction
effect of Condition (pFPA versus cFPA) x Group (DM versus DMPN+NPU) x Mask A (Fore
versus Mid) x Mask B (Lat versus Med) (p=.0.02). Columns represent the condition effect
(within-group differences) in all variables, expressed in mean (SE). Rows represent the group
effect (between-group difference) in all variables, expressed in mean (SE). pFPA: preferred
FPA walking condition; cFPA: corrected FPA walking condition. Mask descriptions. Med
Fore=medial forefoot; Lat Fore=lateral forefoot; Med Mid=medial mid foot; Lat Mid=lateral mid
foot. Variable descriptions. FPA: the value of foot progression angle on the involved (Inv) foot
for both groups under both walking conditions. Absolute FPA change: Absolute difference in
FPA between conditions on the involved (Inv) foot. PPP: peak plantar pressure for each mask.
p (condition): significance values for the condition main effect, 95% CI of the average difference.
p (group): significance values for the group main effect, p<.05.
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Figure 4.1. Regional peak plantar pressure (PPP) in DM (A) and DMPN+NPU (B) participant
groups. pFPA: preferred FPA walking condition; cFPA: corrected FPA walking condition. Mask
descriptions. Med Fore=medial forefoot; Lat Fore=lateral forefoot; Med Mid=medial mid foot;
Lat Mid=lateral mid foot.
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Chapter 5

Summary and Conclusions
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5.1.

Summary
Elevated regional peak plantar pressure (PPP) is an established index of risk dermal

injury in adults with diabetes mellitus and peripheral neuropathy (DMPN)1,2, and is thought to
initiate a lower extremity impairment cascade of medial neuropathic plantar ulcer (NPU)
development and subsequent non-traumatic lower extremity amputation in individuals with
DMPN. Foot progression angle (FPA) is a predictor of elevated regional PPP, a proxy measure
of dermal injury risk in adults with DMPN with and without a history of plantar ulceration1,3.
Prior to this series of investigations, there were no longitudinal or cross-sectional studies that
investigated specific characteristics of FPA in adults with DMPN. Also, to our knowledge there
were no studies that identifying static or dynamic predictors of FPA in adults with DMPN.
Finally, there were no studies probing whether excessive FPA is modifiable in adults with
DMPN, thereby potentially creating a strategy for early rehabilitative intervention to interrupt the
cascade of lower extremity impairment leading to amputation4. The primary objectives of this
research were to determine if specific characteristics of FPA (magnitude and asymmetry) were
altered with disease progression and increasing severity of impairments (Aim 1), to identify
static and dynamic predictors of FPA magnitude (Aim 2), and to examine the effect of reducing
FPA on the regional plantar pressure distribution (Aim 3) in adults with and without DMPN. Our
first hypothesis was there would be a progressive increase in FPA magnitude and a progressive
decrease in the inter-limb FPA asymmetry across a spectrum of participants with and without
DMPN and accompanying history of prior ulceration. Our second hypothesis was that select
static and dynamic predictor variables would explain a significant portion of the variance in FPA.
Our third hypothesis was reduction of FPA in both groups would result in concomitant
decreases in the magnitude of both regional force-time integral (FTI) and regional peak plantar
pressure (PPP) on the medial forefoot mask on the plantar surface of the foot. The following is
a summary of the key findings and clinical relevance from each investigation.
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5.1.a. Specific Aim 1.
5.1.a.1. Key findings. A detailed description of this investigation is outlined in Chapter 2. One
of the key findings from Aim 1 is that participants with diabetes mellitus and peripheral
neuropathy with a reported history of prior ulceration (DMPN+NPU) had a greater FPA
magnitude on both feet than other participant groups of older adults with and without DMPN.
Another key finding from this investigation is there is no difference in the degree of asymmetry
between groups, indicating that FPA asymmetry is not disease-specific, and may be a common
spatial characteristic of normal gait in adults 50 years or older.
5.1.a.2. Clinical relevance. FPA is an established predictor of elevated regional plantar stress,
a proxy measure of neuropathic plantar ulceration risk, in adults with DMPN with and without a
history of NPU development1,3.

Although all groups met the criterion for having an excessive

FPA (FPA>10⁰) in this study, a large FPA in the presence of peripheral neuropathy potentially
exposes individuals with DMPN to elevated regional PPP and, subsequently, to risk for NPU
development. Therefore, there may be more clinical utility in the observation and measurement
of FPA of both feet in adults with DMPN with and without a prior history of NPU development as
part of an assessment of risk of NPU development or recurrence.
5.1.b. Specific Aim 2.
5.1.b.1. Key findings. A detailed description of all findings is outlined in Chapter 3. One of the
key findings from this study is that static (goniometric) measures of limited joint mobility of lower
extremity joint motion are not predictors of FPA, whereas dynamic (gait kinematic and kinetic)
variables 37% of FPA. Additionally, dynamic measures of the thigh and shank transverse plane
motion during the mid stance phase of gait are better predictors of FPA than dynamic measures
of inter-segmental foot motion.
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5.1.b.2. Clinical relevance. These findings suggest rotation of segments proximal to the foot
during gait may better predict FPA in older adults with DMPN. Current interventions that target
static and dynamic predictors of regional PPP within the scope of physical therapist practice are
limited, and are often cost prohibitive5. Identification of predictors of FPA could be clinically
useful in assessing risk for elevated PPPs earlier in the lower extremity impairment cascade
using tools that are widely available in most rehabilitation clinical settings (i.e., goniometers,
inked-moleskin method of gait analysis).
5.1.c. Specific Aim 3.
5.1.c.1. Key findings. A detailed description of all findings is outlined in Chapter 4. In this
investigation, two groups of participants with diabetes mellitus were able to achieve a clinically
meaningful reduction of FPA magnitude using a simple gait modification as the therapeutic
strategy. Another key finding of this study is the observed decrease in stress and load from the
medial forefoot, an area of the foot vulnerable to NPU development, and concomitant increase
in mid foot stress and load in both groups. This shift in regional stress is more pronounced in
the DM group, which indicates that this particular gait modification strategy may more
efficacious prior to the onset of peripheral neuropathy.
5.1.c.1. Clinical relevance. In clinical practice, there are numerous treatment strategies for
offloading plantar sites to promote wound healing or to prevent re-ulceration. Results from this
investigation demonstrate the potential for achieving similar patterns of regional offloading in
areas of the foot vulnerable to dermal injury in adults with DMPN using a cost-effective
therapeutic intervention within the scope of physical therapist practice.
5.2.

Study Limitations and Future Directions

5.2.a. FPA magnitude and asymmetry. FPA magnitude, not inter-limb asymmetry, is diseasespecific in a cross-section of individuals with and without diabetes, peripheral neuropathy, and a
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prior history of ulceration. Future studies should employ a longitudinal study design with more
participants to better determine if there is a progressive increase in FPA magnitude in adults
with DMPN with and without a prior history of ulceration. Determination of the onset of the
development of an excessive FPA could possibly facilitate treatment optimally before the
initiation of the lower extremity impairment cascade of excessive medial peak plantar pressure
(PPP), medial neuropathic plantar ulceration, and non-traumatic amputation.
5.2.b. Predictors of FPA. Our investigation identified transverse rotation position of the thigh
and shank segments during the stance phase of gait as being the strongest predictors of FPA
magnitude, irrespective of disease severity. However, our study did not include radiographic
measures of lower extremity measures of static alignment. Future studies could potentially
extend these findings by examining the radiographic static alignment factors in the proximal and
distal segments of the lower extremity to determine if they also contribute to FPA.
5.2.c .Gait modification. This study was the first to address the utility of reducing FPA (or
positioning the foot closer to midline) as a gait modification strategy using simple visual and
verbal cues. However, this gait instruction and modification was performed over a very brief
series of single steps. Future studies could expand these findings by assessing the effects of
changing FPA over multiple steps, and determining the effects of longer durations of modifying
FPA on other parts of the lower extremity kinetic chain. Finally, we assessed the effect of
modifying FPA under barefoot conditions in order to measure FPA under similar conditions.
We cannot generalize our findings related to the effect of FPA modification to impact of footwear
assessing in-shoe pressures and forces. Future studies should examine the effects of this type
of gait modification strategy on in-shoe measures of stress and load.
5.3.

Conclusions
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This dissertation research has identified specific characteristics and predictors of FPA.
FPA is a predictor of elevated regional plantar stresses and loads in adults with and without
DMPN. This is the first series of investigations to characterize FPA in adults with increasing
severity of impairments attributed to DMPN. This dissertation research provides new information
on characteristics and predictors of FPA, a risk factor for elevated regional PPP in adults with
DMPN. The clinical relevance of the findings from this dissertation research is the earlier
identification of targets for earlier assessment and intervention in the lower extremity impairment
cascade that often culminates in non-traumatic lower extremity amputation in individuals with
DMPN. Furthermore, future studies could examine the efficacy of targeted physical therapy
assessment tools and treatment strategies that may potentially address prevention versus
treatment of NPU based on the unique features of FPA identified in this dissertation.
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Figure 5.1. Impairment cascade of non-traumatic lower extremity amputation
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Appendix 1. Mean (SD) and univariate correlation of foot progression angle (FPA)
measurement using motion capture (Aim 1, Aim 2) and EMED pedobarograph (Aim 3) for a
subset of participants in the current study (N=21).

EMED/MoCap (right)

EMED/MoCap (left)

p

0.79

0.73

<.01

r

Table 1A. Pearson product moment correlation (r) between foot progression angle (FPA)
values derived using EMED pedobarograph (EMED) and motion capture (MoCap).
EMED/MoCap (right): the correlation coefficient for FPA values derived using the EMED
pedobarograph and motion capture (MoCap) for the right foot. EMED/MoCap (left): the
correlation coefficient for FPA values derived using the EMED pedobarograph and motion
capture (MoCap) for the left foot.

FPA (deg)

EMED
(right)

MoCap
(right)

p
(right)

EMED
(left)

MoCap
(left)

p
(left)

-13 (4)

-14 (7)

0.17

-10 (4)

-10 (5)

0.58

Table 1B. Mean (SD) of FPA values derived using the EMED pedobarograph and motion
capture. EMED (right): the mean (SD) for FPA values derived using the EMED pedobarograph.
MoCap (right): the mean (SD) for FPA values using motion capture (MoCap) for the right foot.
EMED (left): the mean (SD) for FPA values using motion capture (MoCap) for the left foot.
MoCap (left): the mean (SD) for FPA values using motion capture (MoCap) for the left foot.
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Figure 1A. Scatter plots of average FPA values for both feet derived using the EMED
pedobarograph (EMED) and using motion capture (MoCap) in the study population for all
dissertation projects (N=21).
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